,"Authors: Brooks, David J.; Brooks, D. J.;Brooks David",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 65 (Of the 328 documents considered for the h-Index, 65 have been cited at least 65 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,17518,2342,2193,4535,1655,23708
2009,Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility,"Edison P., Brooks D.J., Turkheimer F.E., Archer H.A., Hinz R.",10538119,NeuroImage,48,2,0,0,0,0,0,0
2009,Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study,"Williams T.M., Davies S.J.C., Taylor L.G., Daglish M.R.C., Hammers A., Brooks D.J., Nutt D.J., Lingford-Hughes A.",0924977X,European Neuropsychopharmacology,19,10,0,0,0,0,0,0
2009,Phase 1 study of the Pittsburgh compound B derivative18F- flutemetamol in healthy volunteers and patients with probable Alzheimer disease,"Nelissen N., Van Laere K., Thurfjell L., Owenius R., Vandenbulcke M., Koole M., Bormans G., Brooks D.J., Vandenberghe R.",1615505,Journal of Nuclear Medicine,50,8,0,0,0,0,0,0
2009,The risk of exaggerated risk aversion-a life and death struggle for molecular imaging,"Langstrom B., Hoilund-Carlsen P.F., Schwaiger M., Larson S.M., Goldenberg D.M., Melzer A., Engler H., Hicks R., Sundin A., Seppanen M., Hedenstierna G., Grahnen A., Nordberg A., Brooks D., Honore P.H., Borlak J., Bergstrom M., Nielsen B., Vanderheyden J., Watanabe Y., Josephsson R.",16197070,European Journal of Nuclear Medicine and Molecular Imaging,, ,0,0,0,0,0,0
2009,Imaging neurodegeneration in Parkinson's disease,"Pavese N., Brooks D.J.",9254439,Biochimica et Biophysica Acta - Molecular Basis of Disease,1792,7,0,0,0,0,0,0
2009,Proposed neuroimaging criteria for the diagnosis of multiple system atrophy,"Brooks D.J., Seppi K.",8853185,Movement Disorders,24,7,0,0,0,0,0,0
2009,Whole-body biodistribution and radiation dosimetry of 18F-GE067: A radioligand for in vivo brain amyloid imaging,"Koole M., Lewis D.M., Buckley C., Nelissen N., Vandenbulcke M., Brooks D.J., Vandenberghe R., Van Laere K.",1615505,Journal of Nuclear Medicine,50,5,0,0,0,0,1,1
2009,Validation of the Freezing of Gait Questionnaire in patients with Parkinson's disease,"Giladi N., Tolosa E., Tal J., Azulay T., Rascol O., Brooks D.J., Melamed E., Oertel W., Poewe W.H., Stocchi F.",8853185,Movement Disorders,24,5,0,0,0,0,0,0
2009,Microglial activation and amyloid deposition in mild cognitive impairment: A PET study,"Okello A., Rossor M., Brooks D.J., Edison P., Archer H.A., Turkheimer F.E., Kennedy J., Bullock R., Walker Z., Kennedy A., Fox N.",283878,Neurology,72,1,0,0,0,0,2,2
2008,Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography,"Edison P., Chaudhury K.R., Masters C.L., Brooks D.J., Rowe C.C., Rinne J.O., Ng S., Ahmed I., Kemppainen N., Villemagne V.L., O'Keefe G., Nagren K.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",79,12,0,0,0,0,9,9
2008,"Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study","Edison P., Kennedy A., Rossor M., Brooks D.J., Archer H.A., Gerhard A., Hinz R., Pavese N., Turkheimer F.E., Hammers A., Tai Y.F., Fox N.",9699961,Neurobiology of Disease,32,3,0,0,0,0,3,3
2008,Toward a large lightweight mirror for AO: Development of a 1m Ni coated CFRP mirror,"Thompson S.J., Doel A.P., Brooks D., Strangwood M.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,7018, ,0,0,0,0,0,0
2008,Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study,"Politis M., Piccini P., Pavese N., Koh S.-B., Brooks D.J.",144886,Experimental Neurology,214,1,0,0,0,0,7,7
2008,"Dopaminergic action beyond its effect on motor function: Imaging studies (Journal of Neurology (2006) 253, Suppl. 4, (IV/8-IV/15) DOI: 10.1007/s00415-006-4003-5)",Brooks D.J.,3405354,Journal of Neurology,255,9,0,0,0,0,0,0
2008,The role of structural and functional imaging in Parkinsonian states with a description of PET technology,Brooks D.J.,2718235,Seminars in Neurology,28,4,0,0,0,0,0,0
2008,Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain,"Brooks D.J., Mori A., Doder M., Osman S., Luthra S.K., Hirani E., Hume S., Kase H., Kilborn J., Martindill S.",8874476,Synapse,62,9,0,0,0,0,1,1
2008,Second consensus statement on the diagnosis of multiple system atrophy,"Gilman S., Fowler C.J., Kaufmann H., Klockgether T., Lees A., Poewe W., Quinn N., Revesz T., Robertson D., Sandroni P., Seppi K., Wenning G.K., Vidailhet M., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., Wood N.W., Colosimo C., Durr A.",283878,Neurology,71,9,0,0,1,1,19,20
2008,Novel reference region model reveals increased microglial and reduced vascular binding of11C-(R)-PK11195 in patients with Alzheimer's disease,"Tomasi G., Edison P., Bertoldo A., Roncaroli F., Singh P., Gerhard A., Cobelli C., Brooks D.J., Turkheimer F.E.",1615505,Journal of Nuclear Medicine,49,8,0,0,1,1,2,3
2008,Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease,"Reuter I., Piccini P., Tai Y.F., Pavese N., Chaudhuri K.R., Mason S., Polkey C.E., Clough C., Brooks D.J., Barker R.A.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",79,8,0,0,0,0,3,3
2008,Brain dopamine response in human opioid addiction,"Daglish M.R.C., Grasby P., Lingford-Hughes A.R., Nutt D.J., Williams T.M., Wilson S.J., Taylor L.G., Eap C.B., Augsburger M., Giroud C., Brooks D.J., Myles J.S.",71250,British Journal of Psychiatry,193,1,0,0,0,0,1,1
2008,Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease,"Brooks D.J., Leinonen M., Kuoppamaki M., Nissinen H.",3009564,Journal of Neural Transmission,115,6,0,0,0,0,3,3
2008,Cognitive deficits and striato-frontal dopamine release in Parkinson's disease,"Sawamoto N., Piccini P., Hotton G., Pavese N., Thielemans K., Brooks D.J.",68950,Brain,131,5,0,0,1,1,14,15
2008,Technology Insight: Imaging neurodegeneration in Parkinson's disease,Brooks D.J.,1745834X,Nature Clinical Practice Neurology,4,5,0,0,1,1,1,2
2008,"Relationship between weight, levodopa and dyskinesia: The significance of levodopa dose per kilogram body weight","Sharma J.C., Ross I.N., Rascol O., Brooks D.",13515101,European Journal of Neurology,15,5,0,0,0,0,2,2
2008,Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: Implications from a clinical and patient perspective,Brooks D.J.,11766328,Neuropsychiatric Disease and Treatment,4, 1 A,0,0,2,2,1,3
2008,Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting-A retrospective analysis of [15O]H2O PET-CBF studies in 65 patients,"Klinge P.M., Brooks D.J., Samii A., Weckesser E., van den Hoff J., Fricke H., Brinker T., Knapp W.H., Berding G.",3038467,Clinical Neurology and Neurosurgery,110,4,0,0,1,1,2,3
2008,Extrastriatal monoamine neuron function in Parkinson's disease: An 18F-dopa PET study,"Moore R.Y., Whone A.L., Brooks D.J.",9699961,Neurobiology of Disease,29,3,0,0,2,2,6,8
2008,Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (11C)-flumazenil PET study,"Wicks P., Turner M.R., Abrahams S., Hammers A., Brooks D.J., Leigh N.P., Goldstein L.H.",17482968,Amyotrophic Lateral Sclerosis,9,1,0,0,3,3,0,3
2008,A nickel-carbon-fibre composite for large adaptive mirrors: Fabrication methods and properties,"Thompson S.J., Brooks D., Doel A.P.",10944087,Optics Express,16,2,0,0,2,2,0,2
2008,[11C]Flumazenil PET in temporal lobe epilepsy: Do we need an arterial input function or kinetic modeling?,"Hammers A., Panagoda P., Heckemann R.A., Kelsch W., Turkheimer F.E., Brooks D.J., Duncan J.S., Koepp M.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,28,1,0,0,2,2,1,3
2007,Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis,"Turner M.R., Hammers A., Allsop J., Al-Chalabi A., Shaw C., Brooks D.J., Leigh N.P., Andersen P.",17482968,Amyotrophic Lateral Sclerosis,8,6,0,0,1,1,2,3
2007,Assessment of Parkinson's disease with imaging,Brooks D.J.,13538020,Parkinsonism and Related Disorders,13,3,0,0,0,0,2,2
2007,Imaging Parkinson's disease,Brooks D.J.,729752,Handbook of Clinical Neurology,83, ,0,0,0,0,0,0
2007,PET image denoising through a synergistic wavelet transform based multi-resolution analysis of structural and functional datasets,"Turkheimer F.E., Anderson A.N., Boussion N., Pavese N., Brooks D.J., Visvikis D.",0271678X,Journal of Cerebral Blood Flow and Metabolism,27,1,0,0,0,0,0,0
2007,Increased binding potential of [11C]PK11195 in Alzheimer disease using a new SRTM accounting for vascular binding,"Tomasi G., Gerhard A., Turkheimer F., Bertoldo A., Edison P., Roncaroli F., Pavese N., Hammers A., Yen F.T., Cobelli C., Brooks D.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,27,1,0,0,0,0,0,0
2007,Multi-resolution Bayesian regression for parametric imaging of [18F]FDG brain studies,"Hinz R., Edison P., Brooks D.J., Turkheimer F.E.",0271678X,Journal of Cerebral Blood Flow and Metabolism,27,1,0,0,0,0,0,0
2007,"Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus","Ahsan R.L., Brooks D.J., Koepp M.J., Hammers A., Allom R., Gousias I.S., Habib H., Turkheimer F.E., Free S., Lemieux L., Myers R., Duncan J.S.",10538119,NeuroImage,38,2,0,0,4,4,6,10
2007,"Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test-retest data","Hammers A., Asselin M.-C., Turkheimer F.E., Hinz R., Osman S., Hotton G., Brooks D.J., Duncan J.S., Koepp M.J.",10538119,NeuroImage,38,1,0,0,3,3,6,9
2007,Carotid body autotransplantation in Parkinson disease: A clinical and positron emission tomography study,"Minguez-Castellanos A., Villadiego J., Meersmans M., Perez-Garcia M., Brooks D.J., Arjona V., Lopez-Barneo J., Escamilla-Sevilla F., Hotton G.R., Toledo-Aral J.J., Ortega-Moreno A., Mendez-Ferrer S., Martin-Linares J.M., Katati M.J., Mir P.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",78,8,0,1,3,4,5,9
2007,Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease,"Gordin A., Brooks D.J.",3405354,Journal of Neurology,254,4,0,0,0,0,1,1
2007,Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET,"Turner M.R., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., Brooks D.J., Leigh P.N.",3405354,Journal of Neurology,254,8,0,0,2,2,2,4
2007,Reply: Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease [9],"Hu M., Brooks D., Hajnal J.",8853185,Movement Disorders,22,10,0,0,0,0,0,0
2007,Imaging non-dopaminergic function in Parkinson's disease,Brooks D.J.,15361632,Molecular Imaging and Biology,9,4,0,0,2,2,2,4
2007,Brain opioid receptor binding in early abstinence from opioid dependence: Positron emission tomography study,"Williams T.M., Daglish M.R.C., Lingford-Hughes A., Taylor L.G., Hammers A., Brooks D.J., Grasby P., Myles J.S., Nutt D.J.",71250,British Journal of Psychiatry,191, ,0,0,2,2,1,3
2007,Microglial activation in presymptomatic Huntington's disease gene carriers,"Tai Y.F., Pavese N., Gerhard A., Tabrizi S.J., Barker R.A., Brooks D.J., Piccini P.",68950,Brain,130,7,0,3,13,16,11,27
2007,STN stimulation alters pallidal-frontal coupling during response selection under competition,"Thobois S., Hotton G.R., Pinto S., Wilkinson L., Limousin-Dowsey P., Brooks D.J., Jahanshahi M.",0271678X,Journal of Cerebral Blood Flow and Metabolism,27,6,0,1,1,2,0,2
2007,A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195,"Anderson A.N., Pavese N., Edison P., Tai Y.F., Hammers A., Gerhard A., Brooks D.J., Turkheimer F.E.",10538119,NeuroImage,36,1,0,0,4,4,1,5
2007,Imaging microglial activation in Huntington's disease,"Tai Y.F., Pavese N., Gerhard A., Tabrizi S.J., Barker R.A., Brooks D.J., Piccini P.",3619230,Brain Research Bulletin,72, 2-3,0,4,2,6,3,9
2007,Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS,"Turner M.R., Rabiner E.A., Al-Chalabi A., Shaw C.E., Brooks D.J., Leigh P.N., Andersen P.M.",283878,Neurology,68,15,0,1,1,2,0,2
2007,Upregulation of opioid receptor binding following spontaneous epileptic seizures,"Hammers A., Asselin M.-C., Hinz R., Kitchen I., Brooks D.J., Duncan J.S., Koepp M.J.",68950,Brain,130,4,0,1,5,6,5,11
2007,Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: An 18F-dopa PET study,"Tai Y.F., Ahsan R.L., De Yebenes J.G., Pavese N., Brooks D.J., Piccini P.",3009564,Journal of Neural Transmission,114,3,0,1,1,2,2,4
2007,"DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers","Lippa C.F., Emre M., Fahn S., Farmer J.M., Galasko D., Galvin J.E., Goetz C.G., Growdon J.H., Gwinn-Hardy K.A., Hardy J., Heutink P., Duda J.E., Iwatsubo T., Kosaka K., Lee V.M.-Y., Leverenz J.B., Masliah E., McKeith I.G., Nussbaum R.L., Olanow C.W., Ravina B.M., Singleton A.B., Grossman M., Tanner C.M., Trojanowski J.Q., Wszolek Z.K., Hurtig H.I., Aarsland D., Boeve B.F., Brooks D.J., Dickson D.W., Dubois B.",283878,Neurology,68,11,0,12,29,41,19,60
2007,"Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study","Edison P., Kennedy A., Rossor M., Brooks D.J., Archer H.A., Hinz R., Hammers A., Pavese N., Tai Y.F., Hotton G., Cutler D., Fox N.",283878,Neurology,68,7,0,18,30,48,25,73
2007,Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy,"Lawrence A.D., Goerendt I.K., Brooks D.J.",283932,Neuropsychologia,45,1,0,2,7,9,2,11
2007,Reference and target region modeling of [11C]-(R)-PK11195 brain studies,"Turkheimer F.E., Brooks D.J., Edison P., Pavese N., Roncaroli F., Anderson A.N., Hammers A., Gerhard A., Hinz R., Tai Y.F.",1615505,Journal of Nuclear Medicine,48,1,0,5,13,18,3,21
2007,Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space,"Hammers A., Koepp M.J., Chen C.-H., Lemieux L., Allom R., Vossos S., Free S.L., Myers R., Brooks D.J., Duncan J.S.",10659471,Human Brain Mapping,28,1,0,2,2,4,2,6
2006,New developments of brain imaging for Parkinson's Disease and related disorders,"Piccini P., Brooks D.J.",8853185,Movement Disorders,21,12,0,2,5,7,5,12
2006,Erratum: Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease (Annals of Neurology (2006) 59 (459-466)),"Lang A.E., Heywood P., Brodsky M.A., Burchiel K., Kelly P., Dalvi A., Scott B., Stacy M., Turner D., Wooten V.G.F., Elias W.J., Gill S., Laws E.R., Dhawan V., Stoessl A.J., Matcham J., Coffey R.J., Traub M., Patel N.K., Lozano A., Nutt J.G., Penn R., Brooks D.J., Hotton G., Moro E.",3645134,Annals of Neurology,60,6,0,0,0,0,0,0
2006,Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study,"Pavese N., Evans A.H., Tai Y.F., Hotton G., Brooks D.J., Lees A.J., Piccini P.",283878,Neurology,67,9,0,7,11,18,9,27
2006,Development of dyskinesias in a 5-year trial and ropinirole and L-dopa,"Rascol O., Brooks D.J., Korczyn A.D., De Deyn P.P., Clarke C.E., Lang A.E., Abdalla M.",8853185,Movement Disorders,21,11,0,8,19,27,6,33
2006,Preliminary optical design for a 2.2 degree diameter prime focus corrector for the Blanco 4 meter telescope,"Kent S., Worswick S., Bernstein R., Abbott T., Bigelow B., Brooks D., Doel P., Flaugher B., Gladders M., Walker A.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,6269, ,1,0,0,0,0,1
2006,Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model,Brooks D.J.,435325,Wiener Klinische Wochenschrift,118, 19-20,0,0,0,0,1,1
2006,Dopaminergic action beyond its effects on motor function: Imaging studies,Brooks D.J.,3405354,Journal of Neurology,253,4,0,2,0,2,0,2
2006,Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C-PIB positron emission tomography study,"Archer H.A., Edison P., Brooks D.J., Barnes J., Frost C., Yeatman T., Fox N.C., Rossor M.N.",3645134,Annals of Neurology,60,1,3,18,18,36,15,54
2006,Reply: Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease [2],"Piccini P., Pavese N., Hagell P., Reimer J., Bjorklund A., Oertel W.H., Quinn N.P., Brooks D.J., Lindvall O.",68950,Brain,129,7,0,0,0,0,0,0
2006,Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations,"Scherfler C., Khan N.L., Pavese N., Lees A.J., Quinn N.P., Brooks D.J., Piccini P.P.",8853185,Movement Disorders,21,6,0,4,1,5,5,10
2006,Microglial activation correlates with severity in Huntington disease: A clinical and PET study,"Pavese N., Gerhard A., Tai Y.F., Ho A.K., Turkheimer F., Barker R.A., Brooks D.J., Piccini P.",283878,Neurology,66,11,1,20,23,43,8,52
2006,Imaging in Parkinson's Disease: The Role of Monoamines in Behavior,"Brooks D.J., Piccini P.",63223,Biological Psychiatry,59,10,0,7,10,17,9,26
2006,Compulsive drug use linked to sensitized ventral striatal dopamine transmission,"Evans A.H., Pavese N., Lawrence A.D., Tai Y.F., Appel S., Doder M., Brooks D.J., Lees A.J., Piccini P.",3645134,Annals of Neurology,59,5,6,12,20,32,12,50
2006,GDNF in treatment of Parkinson's disease: Response to editorial,"Lang A.E., Nutt J.G., Stacy M., Turner D., Wooten G.F., Penn R.D., Dalvi A., Slevin J., Young B., Gash D., Gerhardt G., Langston J.W., Hutchinson M., Stoessl A.J., Brodsky M., Brooks D.J., Dhawan V., Elias W.J., Lozano A.M., Moro E.",14744422,Lancet Neurology,5,3,2,3,2,5,0,7
2006,Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease,"Lang A.E., Heywood P., Brodsky M.A., Burchiel K., Kelly P., Dalvi A., Scott B., Stacy M., Turner D., Wooten V.G.F., Elias W.J., Gill S., Laws E.R., Dhawan V., Stoessl A.J., Matcham J., Coffey R.J., Traub M., Patel N.K., Lozano A., Nutt J.G., Penn R., Brooks D.J., Hotton G., Moro E.",3645134,Annals of Neurology,59,3,24,49,50,99,39,162
2006,Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin-linked Parkinson's disease,"Hu M.T.M., Scherfler C., Khan N.L., Hajnal J.V., Lees A.J., Quinn N., Wood N.W., Brooks D.J.",8853185,Movement Disorders,21,3,1,4,2,6,2,9
2006,In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease,"Gerhard A., Brooks D.J., Pavese N., Hotton G., Turkheimer F., Es M., Hammers A., Eggert K., Oertel W., Banati R.B.",9699961,Neurobiology of Disease,21,2,5,26,18,44,16,65
2006,Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA study group (EMSA SG),"Geser F., Pellecchia M.T., Barone P., Kim H.T., Hooker J., Quinn N.P., Cardozo A., Tolosa E., Abele M., Klockgether T., Ostergaard K., Wenning G.K., Dupont E., Schimke N., Eggert K.M., Oertel W., Djaldetti R., Poewe W., Dodel R., Tison F., Ghorayeb I., Pollak P., Seppi K., Kolensperger M., Diem A., Deuschl G., Daniels C., Kopper F., Sampaio C., Coelho M., Ferreira J., Rosa M.M., Pirtosek Z., Stampfer-Kountchev M., Lees A.J., Brooks D.J., Fowler C., Revesz T., Gerhard A., Holton J., Schrag A., Wood N., Bozi M., Scaravilli T., Scherfler C., Lindvall O., Widner H., Nilsson C.F., Grabowski M., Krisp A., Moller C., Albanese A., del Sorbo F., Carella F., Meco G., Sawires M., Berciano J., Gonzalez-Mandly A., Giladi N., Gurevich T., Rascol O., Galitzky M., Ory F., Gasser T., Kamm C., Frick C., Buerk K., Maass S., Aquilonius S.-M., Bergquist J., Ndayisaba J.-P., Ulmer H.",8853185,Movement Disorders,21,2,2,7,3,10,3,15
2006,Distributed neural actions of anti-parkinsonian therapies as revealed by PET,"Goerendt I.K., Lawrence A.D., Mehta M.A., Stern J.S., Odin P., Brooks D.J.",3009564,Journal of Neural Transmission,113,1,1,4,0,4,2,7
2006,In vivo imaging of microglial activation with [11C]-PK11195 PET progresive supranuclear palsy,"Gerhard A., Trender-Gerhard I., Turkheimer F., Quinn N.P., Bhatia K.P., Brooks D.J.",8853185,Movement Disorders,21,1,2,8,4,12,1,15
2005,Neurodevelopmental disorders: Preface,"Fleischhacker W.W., Brooks D.",3036995,"Journal of Neural Transmission, Supplement",,69,0,0,0,0,0,0
2005,Factors affecting the clinical outcome after neural transplantation in Parkinson's disease,"Piccini P., Pavese N., Hagell P., Reimer J., Bjorklund A., Oertel W.H., Quinn N.P., Brooks D.J., Lindvall O.",68950,Brain,128,12,9,13,15,28,10,47
2005,Imaging studies in drug development: Parkinson's disease,"Brooks D.J., Lammertsma A.A.",17406749,Drug Discovery Today: Technologies,2,4,0,0,0,0,1,1
2005,Chorea associated with thyroxine replacement therapy,"Isaacs J.D., Rakshi J., Baker R., Brooks D.J., Warrens A.N.",8853185,Movement Disorders,20,12,1,2,1,3,1,5
2005,"Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: Clinical, pathological, olfactory and functional imaging and genetic data","Khan N.L., Ganguly M., Gibbons V., Gandhi S., Vaughan J., Eunson L.H., Katzenschlager R., Gayton J., Lennox G., Revesz T., Nicholl D., Jain S., Bhatia K.P., Quinn N., Brooks D., Lees A.J., Davis M.B., Piccini P., Singleton A.B., Wood N.W., Lynch J.M., Pavese N., Abou-Sleiman P., Holton J.L., Healy D.G., Gilks W.P., Sweeney M.G.",68950,Brain,128,12,13,29,22,51,20,84
2005,Microwave-induced-plasma-assisted synthesis of ternary titanate and niobate phases,"Brooks D.J., Brydson R., Douthwaite R.E.",9359648,Advanced Materials,17,20,4,2,1,3,1,8
2005,Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS,"Turner M.R., Osei-Lah A.D., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., Brooks D.J., Leigh P.N., Mills K.R.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",76,9,4,6,3,9,4,17
2005,Lateralisation of striatal function: Evidence from 18F-dopa PET in Parkinson's disease,"Cheesman A.L., Barker R.A., Lewis S.J.G., Robbins T.W., Owen A.M., Brooks D.J.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",76,9,5,5,4,9,5,19
2005,GABA-benzodiazepine receptor function in alcohol dependence: A combined 11C-flumazenil PET and pharmacodynamic study,"Lingford-Hughes A.R., Wilson S.J., Cunningham V.J., Feeney A., Stevenson B., Brooks D.J., Nutt D.J.",333158,Psychopharmacology,180,4,3,2,2,4,2,9
2005,Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo® (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess®/Comtan® (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment,"Brooks D.J., Agid Y., Eggert K., Widner H., Ostergaard K., Holopainen A.",143022,European Neurology,53,4,9,7,3,10,5,24
2005,Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain,"Love S., Plaha P., Patel N.K., Hotton G.R., Brooks D.J., Gill S.S.",10788956,Nature Medicine,11,7,23,27,19,46,8,77
2005,Mills' and other isolated upper motor neurone syndromes: In vivo study with 11C-(R)-PK11195 PET,"Turner M.R., Gerhard A., Al-Chalabi A., Shaw C.E., Hughes R.A.C., Banati R.B., Brooks D.J., Leigh P.N.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",76,6,2,5,1,6,2,10
2005,Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system,"Remy P., Doder M., Lees A., Turjanski N., Brooks D.",68950,Brain,128,6,21,29,39,68,31,120
2005,Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis,"Hammers A., Koepp M.J., Brooks D.J., Duncan J.S.",139580,Epilepsia,46,6,0,3,4,7,0,7
2005,Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: Studies with [11C]flumazenil PET,"Turner M.R., Hammers A., Al-Chalabi A., Shaw C.E., Andersen P.M., Brooks D.J., Leigh P.N.",68950,Brain,128,6,3,8,6,14,3,20
2005,Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1,"Ros R., Fanjul S., Hernandez J., Cantarero S., Hoenicka J., Jones A., Ahsan R.L., Pavese N., Piccini P., Brooks D.J., Perez-Tur J., Garre P.G., Nyggard T., De Yebenes J.G., Hirano M., Tai Y.F., Ampuero I., Vidal L., Rojo A., Fontan A., Vazquez A.",3645134,Annals of Neurology,57,5,2,4,4,8,4,14
2005,[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS,"Turner M.R., Rabiner E.A., Hammers A., Al-Chalabi A., Grasby P.M., Shaw C.E., Brooks D.J., Leigh P.N.",68950,Brain,128,4,5,9,8,17,3,25
2005,Positron emission tomography and single-photon emission computed tomography in central nervous system drug development,Brooks D.J.,15455343,NeuroRx,2,2,16,5,5,10,2,28
2005,The role of opioids in restless legs syndrome: An [11C] diprenorphine PET study,"Von Spiczak S., Brooks D.J., Whone A.L., Hammers A., Asselin M.-C., Turkheimer F., Tings T., Happe S., Paulus W., Trenkwalder C.",68950,Brain,128,4,14,12,7,19,3,36
2005,"Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): A randomised, double-blind, parallel-group trial","Rascol O., Brooks D.J., Melamed E., Oertel W., Poewe W., Stocchi F., Tolosa E.",1406736,Lancet,365,9463,58,42,36,78,17,153
2005,The role of radiotracer imaging in Parkinson disease,"Ravina B., Guttman M., Gwinn-Hardy K., McFarland H., Innis R., Katz R.G., Kieburtz K., Kish S.J., Lange N., Langston J.W., Marek K., Eidelberg D., Morin L., Moy C., Murphy D., Oertel W.H., Oliver G., Palesch Y., Powers W., Seibyl J., Sethi K.D., Shults C.W., Ahlskog J.E., Sheehy P., Stoessl A.J., Holloway R., Albin R.L., Brooks D.J., Carbon M., Dhawan V., Feigin A., Fahn S.",283878,Neurology,64,2,31,38,33,71,17,119
2005,"Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation","Khan N.L., Scherfler C., Graham E., Bhatia K.P., Quinn N., Lees A.J., Brooks D.J., Wood N.W., Piccini P.",283878,Neurology,64,1,20,11,6,17,14,51
2005,Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies,"Melichar J.K., Lingford-Hughes A., Nutt D.J., Hume S.P., Williams T.M., Daglish M.R.C., Taylor L.G., Ahmad R., Malizia A.L., Brooks D.J., Myles J.S.",223565,Journal of Pharmacology and Experimental Therapeutics,312,1,8,6,4,10,1,19
2005,Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: Clinical follow up study of 13 cases,"Chaudhuri K.R., Buxton-Thomas M., Dhawan V., Peng R., Meilak C., Brooks D.J.",223050,"Journal of Neurology, Neurosurgery and Psychiatry",76,1,7,6,13,19,5,31
2004,New results from the Precessions polishing process scaled to larger sizes,"Walker D.D., McCavana G., Morton R., Riley D., Simms J., Beaucamp A.T.H., Brooks D., Doubrovski V., Cassie M., Dunn C., Freeman R., King A., Libert M.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,5494, ,3,1,1,2,6,11
2004,Recent development of Precessions polishing for larger components and free-form surfaces,"Walker D.D., McCavana G., Morton R., Riley D., Simms J., Beaucamp A.T.H., Brooks D., Doubrovski V., Cassie M., Dunn C., Freeman R., King A., Libert M.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,5523, ,1,1,0,1,2,4
2004,Opioid binding in DYT1 primary torsion dystonia: An 11C-diprenorphine PET study,"Whone A.L., Von Spiczak S., Edwards M., Valente E.-M., Hammers A., Bhatia K.P., Brooks D.J.",8853185,Movement Disorders,19,12,2,2,1,3,0,5
2004,Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS),"Wenning G.K., Scaravilli T., Bozi Ma., Gilman S., Shults C.W., Quinn N.P., Rascol O., Poewe W., Dupont E., Ostergaard K., Tison F., Tolosa E., Klockgether T., Dodel R., Abele M., Pollak P., Geser F., Stamfer M., Deuschl G., Daniels C., Coelho M., Seppi K., Pirtosek Z., Brooks D.J., Fowler C., Lees A., Mathias C.J., Revesz T., Gerhard A., Holton J., Schrag A., Wood N., Sampiao C., Lindvall O., Widner H., Grabowski M., Nilsson C.F., Oertel W., Eggert K.M., Schimke N., Albanese A., del Sorbo F., Barone P., Diem A., Carella F., Djaljetti R., Meco G., Berciano J., Gonzalez-Mandly A., Giladi N., Gurevich T., Gasser T., Kamm C., Aquilonius S.-M., Yekhlef F., Bergquist J., Ghorayeb I., Ory F., Galitzky M.",8853185,Movement Disorders,19,12,16,12,10,22,5,43
2004,Positron Emission Tomography Imaging of Transplant Function,Brooks D.J.,15455343,NeuroRx,1,4,3,4,1,5,1,9
2004,In vivo imaging of microglial activation with [11C](R -PK11195 PET in corticobasal degeneration,"Gerhard A., Watts J., Trender-Gerhard I., Turkheimer F., Banati R.B., Bhatia K., Brooks D.J.",8853185,Movement Disorders,19,10,11,10,3,13,2,26
2004,Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease,"Fern-Pollak L., Whone A.L., Brooks D.J., Mehta M.A.",283932,Neuropsychologia,42,14,7,2,2,4,0,11
2004,"Role of the palliative care pharmacist: An example from North Derbyshire, UK","Austwick E., Brooks D.",9699260,Progress in Palliative Care,12,1,0,0,1,1,0,1
2004,A technique for standardized central analysis of 6-18F-fluoro-L- DOPA PET data from a multicenter study,"Whone A.L., Bailey D.L., Remy P., Pavese N., Brooks D.J.",1615505,Journal of Nuclear Medicine,45,7,3,1,3,4,1,8
2004,Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism,"Scherfler C., Piccini P.P., Khan N.L., Pavese N., Eunson L., Graham E., Lees A.J., Quinn N.P., Wood N.W., Brooks D.J.",68950,Brain,127,6,25,9,6,15,6,46
2004,[123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after ?9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in Tourette patients,"Berding G., Hofmann M., Knoop B.O., Brooks D.J., Emrich H.M., Knapp W.H., Muller-Vahl K., Schneider U., Gielow P., Fitschen J., Stuhrmann M., Harke H., Buchert R., Donnerstag F.",63223,Biological Psychiatry,55,9,11,4,2,6,1,18
2004,Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study,"Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B.",9699961,Neurobiology of Disease,15,3,35,27,10,37,10,82
2004,Neuroimaging in Parkinson's Disease,Brooks D.J.,15455343,NeuroRx,1,2,11,7,3,10,5,26
2004,Cardiovascular effects of methamphetamine in Parkinson's disease patients,"Pavese N., Rimoldi O., Gerhard A., Brooks D.J., Piccini P.",8853185,Movement Disorders,19,3,2,2,2,4,0,6
2004,The Human Premotor Cortex Is 'Mirror' only for Biological Actions,"Tai Y.F., Scherfler C., Brooks D.J., Sawamoto N., Castiello U.",9609822,Current Biology,14,2,23,24,16,40,11,74
2004,Safety and tolerability of COMT inhibitors,"Brooks D.J., Koller, Olanow, Hauser, Reinikainen, Poewe, Hubble, Stocchi",283878,Neurology,62,1,9,3,4,7,2,18
2004,Reward Processing in Health and Parkinson's Disease: Neural Organization and Reorganization,"Goerendt I.K., Lawrence A.D., Brooks D.J.",10473211,Cerebral Cortex,14,1,4,4,3,7,3,14
2003,The role of the pharmacist as a member of the palliative care team,"Austwick E., Brooks D.",9699260,Progress in Palliative Care,11,6,1,0,0,0,0,1
2003,Precessions aspheric polishing: - New results from the development programme,"Walker D.D., Riley D., Simms J., Beaucamp A.T.H., Bingham R.G., Brooks D., Freeman R., Kim S.W., King A., McCavana G., Morton R.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,5180, ,5,0,0,0,1,6
2003,Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease,"Brooks D.J., Frey K.A., Marek K.L., Oakes D., Paty D., Prentice R., Shults C.W., Stoessl A.J.",144886,Experimental Neurology,184,1,33,14,13,27,8,68
2003,Real-pet and consort (multiple letters),"Morrish P.K., Brooks D.J., Whone A.L.",3645134,Annals of Neurology,54,5,2,2,0,2,0,4
2003,Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica.,"Kury S., Brooks D., Schuster V., Scoul C., Dreno B., Bezieau S., Moisan J.P., Kharfi M., Kamoun R., Taieb A., Mallet E., Baudon J.J., Glastre C., Michel B., Sebag F.",10981004,Human mutation,22,4,13,2,3,5,3,21
2003,[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy,"Gerhard A., Quinn N., Schwarz J., Brooks D.J., Banati R.B., Goerres G.B., Cagnin A., Myers R., Gunn R.N., Turkheimer F., Good C.D., Mathias C.J.",283878,Neurology,61,5,26,16,6,22,1,49
2003,Monoamine neuron innervation of the normal human brain: An 18F-DOPA PET study,"Moore R.Y., Whone A.L., McGowan S., Brooks D.J.",68993,Brain Research,982,2,11,4,5,9,4,24
2003,"Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe","Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S.",10659471,Human Brain Mapping,19,4,25,29,21,50,12,87
2003,"Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: A randomised, placebo controlled, double blind, six month study","Brooks D.J., Sagar H.",223050,Journal of Neurology Neurosurgery and Psychiatry,74,8,44,6,10,16,8,68
2003,PET studies on the function of dopamine in health and Parkinson's disease,Brooks D.J.,778923,Annals of the New York Academy of Sciences,991, ,7,2,0,2,3,12
2003,Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study,"Whone A.L., Remy P., Poewe W.H., Hauser R.A., Brooks D.J., Watts R.L., Stoessl A.J., Davis M., Reske S., Nahmias C., Lang A.E., Rascol O., Ribeiro M.J.",3645134,Annals of Neurology,54,1,195,47,53,100,34,329
2003,Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients,"Hammers A., Koepp M.J., Richardson M.P., Hurlemann R., Brooks D.J., Duncan J.S.",68950,Brain,126,6,20,5,5,10,3,33
2003,Endogenous dopamine release after pharmacological challenges in Parkinson's disease,"Piccini P., Pavese N., Brooks D.J.",3645134,Annals of Neurology,53,5,42,4,3,7,10,59
2003,Active profiling and polishing for efficient control of material removal from large precision surfaces with moderate asphericity,"Kim S.-W., Walker D., Brooks D.",9574158,Mechatronics,13,4,0,1,0,1,0,1
2003,Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A pet study,"Pavese N., Piccini P., Andrews T.C., Brooks D.J., Ho A.K., Rosser A.E., Barker R.A., Robbins T.W., Sahakian B.J., Dunnett S.B.",68950,Brain,126,5,27,13,10,23,7,57
2003,Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease,"Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P.",10788956,Nature Medicine,9,5,268,72,66,138,41,447
2003,Imaging end points for monitoring neuroprotection in Parkinson's disease,"Brooks D.J., Schapira, Tatton, Beal, Stocchi, Marek, Olanow, Rascol",3645134,Annals of Neurology,53,3,34,6,3,9,1,44
2003,"The 'Precessions' tooling for polishing and figuring flat, spherical and aspheric surfaces","Walker D.D., Brooks D., King A., Freeman R., Morton R., McCavana G., Kim S.-W.",10944087,Optics Express,11,8,15,8,8,16,5,36
2003,Tremor in Parkinson's disease and serotonergic dysfunction: An 11C-WAY 100635 PET study,"Doder M., Rabiner E.A., Turjanski N., Lees A.J., Brooks D.J.",283878,Neurology,60,4,34,11,18,29,10,73
2003,Plasticity of the nigropallidal pathway in Parkinson's disease,"Whone A.L., Moore R.Y., Piccini P.P., Brooks D.J.",3645134,Annals of Neurology,53,2,29,11,11,22,7,58
2003,Dopamine release during sequential finger movements in health and Parkinson's disease: A PET study,"Goerendt I.K., Messa C., Lawrence A.D., Grasby P.M., Piccini P., Brooks D.J.",68950,Brain,126,2,26,5,11,16,4,46
2003,[123I]?-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy,"Berding G., Knapp W.H., Brucke Th., Odin P., Brooks D.J., Kolbe H., Gielow P., Harke H., Knoop B.O., Dengler R.",295566,NuklearMedizin,42,1,14,3,1,4,5,23
2002,A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: An 18F-dopa PET study,"Rakshi J.S., Pavese N., Uema T., Ito K., Morrish P.K., Bailey D.L., Brooks D.J.",3009564,Journal of Neural Transmission,109,12,17,5,3,8,3,28
2002,The precessions process for efficient production of aspheric optics for large telescopes and their instrumentation,"Walker D.D., Riley D., Simms J., Beaucamp A.T.H., Bingham R.G., Brooks D., Freeman R., Kim S.W., King A., McCavana G., Morton R.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,4842, ,11,0,0,0,1,12
2002,Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An 18F-dopa PET study,"Khan N.L., Valente E.M., Bentivoglio A.R., Wood N.W., Albanese A., Brooks D.J., Piccini P.",3645134,Annals of Neurology,52,6,57,17,15,32,9,98
2002,Novel CNC polishing process for control of form and texture on aspheric surfaces,"Walker D.D., Beaucamp A.T.H., Brooks D., Freeman R., King A., McCavana G., Morton R., Riley D., Simms J.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,4767, ,3,1,2,3,5,11
2002,A H215O positron emission tomography study on mental imagery of movement sequences - The effect of modulating sequence length and direction,"Boecker H., Ceballos-Baumann A.O., Bartenstein P., Dagher A., Forster K., Haslinger B., Brooks D.J., Schwaiger M., Conrad B.",10538119,NeuroImage,17,2,18,7,5,12,2,32
2002,An imaging study of parkinsonism among African-Caribbean and Indian London communities,"Hu M.T.M., Chaudhuri K.R., Jorosz J., Yaguez L., Brooks D.J.",8853185,Movement Disorders,17,6,4,0,1,1,0,5
2002,Imaging: MRS/MRI/PET/SPECT: Summary,"Leigh P.N., Simmons A., Williams S., Williams V., Turner M., Brooks D.",14660822,Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders,3,1,6,2,1,3,0,9
2002,Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI,"Hammers A., Koepp M.J., Hurlemann R., Thom M., Richardson M.P., Brooks D.J., Duncan J.S.",68950,Brain,125,10,26,4,6,10,4,40
2002,Progression of nigrostriatal dysfunction in a parkin kindred: An [18F]dopa PET and clinical study,"Khan N.L., Brooks D.J., Pavese N., Sweeney M.G., Wood N.W., Lees A.J., Piccini P.",68950,Brain,125,10,42,12,2,14,8,64
2002,Imaging the GABA-benzodiazepine receptor subtype containing the ?-5-subunit in vivo with [11C]Ro15 4513 positron emission tomography,"Lingford-Hughes A., Hume S.P., Feeney A., Hirani E., Osman S., Cunningham V.J., Pike V.W., Brooks D.J., Nutt D.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,22,7,19,2,4,6,2,27
2002,Dyskinesias following neural transplantation in Parkinson's disease,"Hagell P., Quinn N., Brooks D.J., Lindvall O., Piccini P., Bjorklund A., Brundin P., Rehncrona S., Widner H., Crabb L., Pavese N., Oertel W.H.",10976256,Nature Neuroscience,5,7,83,19,21,40,15,138
2002,Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: A 6-[18F]fluoro-L-dopa PET study,"Ito K., Kachi T., Brooks D.J., Nagano-Saito A., Kato T., Arahata Y., Nakamura A., Kawasumi Y., Hatano K., Abe Y., Yamada T.",68950,Brain,125,6,29,13,10,23,5,57
2002,"A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa","Brunt E.R., Brooks D.J., Korczyn A.D., Montastruc J.-L., Stocchi F.",3009564,Journal of Neural Transmission,109,4,27,6,5,11,1,39
2002,Pharmacist's input into a palliative care clinic,"Austwick E.A., Brown L.C., Goodyear K.H., Brooks D.J.",316873,Pharmaceutical Journal,268,7190,4,1,1,2,1,7
2002,Increased dopamine tone during meditation-induced change of consciousness,"Kjaer T.W., Bertelsen C., Piccini P., Brooks D., Alving J., Lou H.C.",9266410,Cognitive Brain Research,13,2,24,5,4,9,6,39
2002,Implementation and application of a brain template for multiple volumes of interest,"Hammers A., Koepp M.J., Free S.L., Brett M., Richardson M.P., Labbe C., Cunningham V.J., Brooks D.J., Duncan J.",10659471,Human Brain Mapping,15,3,19,12,6,18,3,40
2002,18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease,"Ceravolo R., Piccini P., Bailey D.L., Jorga K.M., Bryson H., Brooks D.J.",8874476,Synapse,43,3,27,4,4,8,2,37
2002,Two large British kindreds with familial Parkinson's disease: A clinico-pathological and genetic study,"Nicholl D.J., Piccini P., Daniel S.E., Lennox G.G., Brooks D.J., Williams A.C., Wood N.W., Vaughan J.R., Khan N.L., Ho S.L., Aldous D.E.W., Lincoln S., Farrer M., Gayton J.D., Davis M.B.",68950,Brain,125,1,11,0,0,0,1,12
2002,The Zeeko/UCL process for polishing large lenses and prisms,"Walker D.D., Freeman R., McCavana G., Morton R., Riley D., Simms J., Brooks D., Kim E.D., King A.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,4411, ,2,0,1,1,1,4
2002,Diagnosis and management of atypical Parkinsonian syndromes,Brooks D.J.,14737086,Neurology in Practice,72,1,6,4,3,7,1,14
2001,Functional imaging studies on dopamine and motor control,Brooks D.J.,3009564,Journal of Neural Transmission,108,11,14,1,4,5,1,20
2001,The first aspheric form and texture results from a production machine embodying the precession process,"Walker D.D., Brooks D., Freeman R., King A., McCavana G., Morton R., Riley D., Simms J.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,4451, ,14,2,3,5,3,22
2001,Updated guidelines for the management of Parlcinson's disease,"Bhatia K., Williams A.C., Brooks D.J., Burn D.J., Clarke C.E., Grosset D.G., MacMahon D.G., Fer J.P., Schapira A.H.V., Stewart D.",14623935,Hospital Medicine,62,8,18,2,0,2,0,20
2001,Benzodiazepine-GABAA receptor binding is very low in dysembryoplastic neuroepithelial tumor: A PET study,"Richardson M.P., Hammers A., Brooks D.J., Duncan J.S.",139580,Epilepsia,42,10,9,4,1,5,1,15
2001,Familial progressive supranuclear palsy: Detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography,"Piccini P., De Yebenez J., Lees A.J., Ceravolo R., Turjanski N., Pramstaller P., Brooks D.J.",39942,Archives of Neurology,58,11,14,3,2,5,4,23
2001,Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury,"Banati R.B., Cagnin A., Brooks D.J., Gunn R.N., Myers R., Jones T., Birch R., Anand P.",9594965,NeuroReport,12,16,13,6,2,8,1,22
2001,Evaluation of [4-O-methyl-11C]KW-6002 as a potential PET ligand for mapping central adenosine A2A receptors in rats,"Hirani E., Brooks D.J., Gillies J., Karasawa A., Shimada J., Kase H., Opacka-Juffry J., Osman S., Luthra S.K., Hume S.P.",8874476,Synapse,42,3,9,1,4,5,2,16
2001,Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET,"Berding G., Fricke H., Dengler R., Samii M., Knapp W.H., Odin P., Brooks D.J., Nikkhah G., Matthies C., Peschel T., Shing M., Kolbe H., van den Hoff J.",8853185,Movement Disorders,16,6,32,4,3,7,8,47
2001,Cerebral blood flow activation studies in Parkinson's disease.,Brooks D.J.,913952,Advances in neurology,86, ,2,0,0,0,0,2
2001,Central benzodiazepine receptors in malformations of cortical development: A quantitative study,"Hammers A., Koepp M.J., Richardson M.P., Labbe C., Brooks D.J., Cunningham V.J., Duncan J.S.",68950,Brain,124,8,36,3,2,5,6,47
2001,Depression in Parkinson's disease,"Brooks D.J., Doder M.",13507540,Current Opinion in Neurology,14,4,13,6,5,11,4,28
2001,In-vivo measurement of activated microglia in dementia,"Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B.",1406736,Lancet,358,9280,185,44,29,73,17,275
2001,Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline,"Hu M.T.M., White S.J., Chaudhuri K.R., Morris R.G., Bydder G.M., Brooks D.J.",3009564,Journal of Neural Transmission,108,5,15,5,3,8,2,25
2001,A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of parkinson's disease,"Hu M.T.M., White S.J., Herlihy A.H., Chaudhuri K.R., Hajnal J.V., Brooks D.J.",283878,Neurology,56,9,22,5,5,10,4,36
2001,Long-Term observations of patients receiving transdermal fentanyl after a randomized trial,"Nugent M., Davis C., Brooks D., Ahmedzai S.H.",8853924,Journal of Pain and Symptom Management,21,5,32,0,3,3,2,37
2001,Treatment of early onset Parkinson's disease with ropinirole [14] (multiple letters),"Ponsford J.R., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,70,3,0,0,0,0,0,0
2001,Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy,"Hammers A., Koepp M.J., Labbe C., Brooks D.J., Thom M., Cunningham V.J., Duncan J.S.",283878,Neurology,56,7,43,9,9,18,3,64
2001,Motor imagery in normal subjects and Parkinson's disease patients: An H215O PET study,"Samuel M., Ceballos-Baumann A.O., Boecker H., Brooks D.J.",9594965,NeuroReport,12,4,13,5,1,6,3,22
2000,The effects of surgical treatment of Parkinson's disease on brain function: PET findings,"Brooks D.J., Samuel M.",283878,Neurology,55,12,11,1,1,2,1,14
2000,PET studies and motor complications in Parkinson's disease,Brooks D.J.,1662236,Trends in Neurosciences,23,10,10,2,1,3,1,14
2000,Microglial activation in neurodegenerative diseases: A PET study using [11C](R)-PK11195,"Banati R.B., Cagnin A., Myers R., Gunn R.N., Turkheimer F.E., Brooks D.J., Jones T.",10538119,NeuroImage,11,6,0,0,0,0,0,0
2000,Monitoring neuroprotection and restorative therapies in Parkinson's disease with PET,Brooks D.J.,3036995,"Journal of Neural Transmission, Supplement",,60,18,0,0,0,1,19
2000,Novel automated process for aspheric surfaces,"Bingham R.G., Walker D.D., Kim D.-H., Brooks D., Freeman R., Riley D.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,4093, ,18,5,5,10,5,33
2000,Non-invasive in vivo imaging of transplant function,"Brooks D.J., Piccini P.",796123,Progress in Brain Research,127, ,4,0,0,0,0,4
2000,The role of entacapone in the management of Parkinson's disease,"Brooks D.J., Forsvth D., Plavfer J.R., Williams A.C.",14623935,Hospital Medicine,61,4,5,0,0,0,0,5
2000,Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts,"Piccini P., Rehncrona S., Widner H., Brooks D.J., Lindvall O., Bjorklund A., Brundin P., Hagell P., Ceravolo R., Oertel W., Quinn N., Samuel M.",3645134,Annals of Neurology,48,5,82,7,9,16,10,108
2000,Extramotor involvement in ALS: PET studies with the GABA(A) ligand [11C]flumazenil,"Lloyd C.M., Richardson M.P., Brooks D.J., Al-Chalabi A., Leigh P.N.",68950,Brain,123,11,27,7,9,16,3,46
2000,The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man,"White R.P., Deane C., Hindley C., Bloomfield P.M., Cunningham V.J., Vallance P., Brooks D.J., Markus H.S.",0022510X,Journal of the Neurological Sciences,178,1,7,1,4,5,2,14
2000,Long-term changes of GABAergic function in the sensorimotor cortex of amputees. A combined magnetic stimulation and 11C-flumazenil PET study,"Capaday C., Richardson M.P., Rothwell J.C., Brooks D.J.",144819,Experimental Brain Research,133,4,9,0,0,0,0,9
2000,Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease,"Brundin P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Oertel W.H., Quinn N.P., Rehncrona S., Lindvall O., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P.",68950,Brain,123,7,93,11,13,24,7,124
2000,Research goals in progressive supranuclear palsy,"Litvan I., Standaert D., Brooks D.J., Price D., Dickson D.W., Buttner-Ennever J.A., Delacourte A., Hutton M., Dubois B., Golbe L.I., Hallett M., Schellenberg G.D.",8853185,Movement Disorders,15,3,13,1,1,2,0,15
2000,Self-initiated versus externally triggered movements. II. The effect of movement predictability on regional cerebral blood flow,"Jenkins I.H., Jahanshahi M., Jueptner M., Passingham R.E., Brooks D.J.",68950,Brain,123,6,89,10,20,30,14,133
2000,Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis,"Jalan R., Turjanski N., Taylor-Robinson S.D., Koepp M.J., Richardson M.P., Wilson J.A., Bell J.D., Brooks D.J.",175749,Gut,46,4,20,2,2,4,3,27
2000,Dopamine agonists: Their role in the treatment of Parkinson's disease,Brooks D.J.,223050,Journal of Neurology Neurosurgery and Psychiatry,68,6,17,1,2,3,1,21
2000,A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa,"Rascol O., Brooks D.J., Korczyn A.D., De Deyn P.P., Clarke C.E., Lang A.E.",284793,New England Journal of Medicine,342,20,491,81,83,164,41,696
2000,Imaging basal ganglia function,Brooks D.J.,218782,Journal of Anatomy,196,4,13,1,2,3,0,16
2000,The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease,"Piccini P., Brooks D.J., Korpela K., Pavese N., Karlsson M., Gordin A.",223050,Journal of Neurology Neurosurgery and Psychiatry,68,5,29,4,2,6,2,37
2000,Neuroimaging of dyskinesia,"Brooks D.J., Piccini P., Turjanski N., Samuel M.",3645134,Annals of Neurology,47,4,26,4,3,7,1,34
2000,Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease,"Hagell P., Crabb L., Pogarell O., Schrag A., Widner H., Brooks D.J., Oertel W.H., Quinn N.P., Lindvall O.",8853185,Movement Disorders,15,2,19,4,1,5,1,25
2000,Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease,Brooks D.J.,9391517,"Journal of Neurology, Supplement",247,2,38,6,6,12,0,50
2000,Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans,"Rogers R.D., Andrews T.C., Grasby P.M., Brooks D.J., Robbins T.W.",0898929X,Journal of Cognitive Neuroscience,12,1,132,25,23,48,19,199
2000,Cortical dysfunction in non-demented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET study,"Hu M.T.M., Turjanski N., Brooks D.J., Taylor-Robinson S.D., Chaudhuri K.R., Bell J.D., Labbe C., Cunningham V.J., Koepp M.J., Hammers A., Morris R.G.",68950,Brain,123,2,48,7,11,18,8,74
2000,Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome,"Reuter I., Hu M.T.M., Andrews T.C., Brooks D.J., Clough C., Ray Chaudhuri K.",223050,Journal of Neurology Neurosurgery and Psychiatry,68,2,19,3,2,5,3,27
2000,11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI,"Koepp M.J., Hammers A., Labbe C., Woermann F.G., Brooks D.J., Duncan J.S.",283878,Neurology,54,2,43,5,4,9,3,55
2000,Functional imaging studies in corticobasal degeneration.,Brooks D.J.,913952,Advances in neurology,82, ,12,2,0,2,0,14
2000,Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK,"Chaudhuri K.R., Hu M.T.M., Brooks D.J.",8853185,Movement Disorders,15,1,17,5,4,9,1,27
2000,Optimum delay and mean square error using a mixed crosscorrelation and constant modulus algorithm,"Brooks D.J., Lambotharan S., Chambers J.A.",13502425,IEE Proceedings: Communications,147,1,0,0,0,0,0,0
2000,"Modeling the circulation in Penobscot Bay, Maine","Xue Huijie, Xu Yu., Brooks David, Pettigrew Neal, Wallinga John",,Proceedings of the International Conference on Estuarine and Coastal Modeling,, ,0,0,0,0,0,0
1999,[11C] (R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis,"Banati R.B., Goerres G.W., Myers R., Gunn R.N., Turkheimer F.E., Kreutzberg G.W., Brooks D.J., Jones T., Duncan J.S.",283878,Neurology,53,9,74,7,4,11,6,91
1999,"PET imaging of motor sequence control: Pure motor imagination of increasingly complex finger sequences, A parametric 3D H215O PET study","Boecker H., Ceballos-Baumann A.O., Bartenstein P., Siebner H.R., Forster K., Dagher A., Haslinger B., Brooks D.J., Conrad B.",10538119,NeuroImage,9,6,0,0,0,0,0,0
1999,The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: A PET study,"White R.P., Hindley C., Bloomfield P.M., Cunningham V.J., Vallance P., Brooks D.J., Markus H.S.",0271678X,Journal of Cerebral Blood Flow and Metabolism,19,6,23,1,2,3,0,26
1999,Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient,"Piccini P., Widner H., Lindvall O., Brooks D.J., Bjorklund A., Gunn R.N., Grasby P.M., Rimoldi O., Brundin P., Hagell P., Rehncrona S.",10976256,Nature Neuroscience,2,12,252,20,32,52,15,319
1999,Huntington's disease progression. PET and clinical observations,"Andrews T.C., Brooks D.J., Weeks R.A., Turjanski N., Gunn R.N., Watkins L.H.A., Sahakian B., Hodges J.R., Rosser A.E., Wood N.W.",68950,Brain,122,12,42,9,8,17,6,65
1999,Unilateral pallidotomy for Parkinson's disease: Results after more than 1 year,"Schrag A., Quinn N.P., Samuel M., Caputo E., Scaravilli T., Troyer M., Marsden C.D., Thomas D.G.T., Lees A.J., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,67,4,20,1,0,1,1,22
1999,Mapping the network for planning: A correlational PET activation study with the Tower of London task,"Dagher A., Owen A.M., Boecker H., Brooks D.J.",68950,Brain,122,10,104,15,13,28,12,144
1999,Etiology of Parkinson's disease: contributions from 18F-DOPA positron emission tomography.,"Piccini P., Brooks D.J.",913952,Advances in neurology,80, ,10,3,0,3,0,13
1999,"Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease. A 3D [18F]dopa-PET study","Rakshi J.S., Brooks D.J., Uema T., Ito K., Bailey D.L., Morrish P.K., Ashburner J., Dagher A., Jenkins I.H., Friston K.J.",68950,Brain,122,9,81,7,9,16,6,103
1999,Radiolabelling of KW-6002 with [11C]iodomethane for studies of the adenosine A(2A) receptor in vivo,"Gillies J., Luthra S.K., Brady F., Karasawa A., Shimada J., Kase H., Brooks D.J.",3624803,Journal of Labelled Compounds and Radiopharmaceuticals,42,1,3,0,1,1,0,4
1999,Temporally-specific retrograde amnesia in two cases of discrete bilateral hippocampal pathology,"Kapur N., Brooks D.J.",10509631,Hippocampus,9,3,33,7,5,12,3,48
1999,Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: A proton MR spectroscopy study,"Hu M.T.M., Taylor-Robinson S.D., Ray Chaudhuri K., Bell J.D., Morris R.G., Clough C., Brooks D.J., Turjanski N.",223050,Journal of Neurology Neurosurgery and Psychiatry,67,1,23,3,5,8,0,31
1999,Identification of the cerebral loci processing human swallowing with H215O PET activation,"Hamdy S., Rothwell J.C., Brooks D.J., Bailey D., Aziz Q., Thompson D.G.",223077,Journal of Neurophysiology,81,4,64,8,15,23,9,96
1999,Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease,"Ito K., Morrish P.K., Rakshi J.S., Uema T., Ashburner J., Bailey D.L., Friston K.J., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,66,6,34,1,3,4,2,40
1999,Sequential bilateral transplantation in Parkinson's disease. Effects of the second graft,"Hagell P., Odin P., Wenning G.K., Morrish P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O., Schrag A., Piccini P., Jahanshahi M., Brown R., Rehncrona S., Widner H., Brundin P., Rothwell J.C.",68950,Brain,122,6,94,12,9,21,5,120
1999,The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins,"Piccini P., Burn D.J., Ceravolo R., Maraganore D., Brooks D.J.",3645134,Annals of Neurology,45,5,156,11,7,18,7,181
1999,A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease,"Taylor-Robinson S.D., Turjanski N., Bhattacharya S., Seery J.P., Sargentoni J., Brooks D.J., Bryant D.J., Cox I.J.",8857490,Metabolic Brain Disease,14,1,9,3,3,6,0,15
1999,Association of abnormal cerebellar activation with motor learning difficulties in dyslexic adults,"Nicolson R.I., Fawcett A.J., Berry E.L., Jenkins I.H., Dean P., Brooks D.J.",1406736,Lancet,353,9165,80,13,13,26,5,111
1999,Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies,"Turjanski N., Lees A.J., Brooks D.J.",283878,Neurology,52,5,160,19,23,42,11,213
1999,Functional imaging of Parkinson's disease: Is it possible to detect brain areas for specific symptoms,Brooks D.J.,3036995,"Journal of Neural Transmission, Supplement",,56,17,2,1,3,0,20
1999,"Mach-Zehnder type, evanescent-wave bio-sensor, in ion-exchanged glass, using periodically segmented waveguide","Weissman Z., Brand E., Tsimberov I., Brooks D., Ruschin S., Goldberg D.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,3596, ,1,0,0,0,0,1
1999,Electro-optic ADD-DROP tunable filter based on asymmetric directional coupler,"Brooks David, Ruschin Shlomo",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,3620, ,0,0,0,0,0,0
1999,Radiosynthesis of the dopamine D1 agonist R-(+)-[11C]SKF 82957. - A simple [11C]methylation?,"Gillies J., Luthra S.K., Brady F., Brooks D.J.",3624803,Journal of Labelled Compounds and Radiopharmaceuticals,42,1,1,0,0,0,0,1
1998,Guidelines for the management of Parkinson's disease,"Bhatia K., Brooks D.J., Burn D.J., Clarke C.E., Playfer J., Sawle G.V., Schapira A.H.V., Stewart D., Williams A.C.",14623935,Hospital Medicine,59,6,10,0,1,1,0,11
1998,Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET,"Andrews T.C., Brooks D.J.",13574310,Molecular Medicine Today,4,12,15,3,0,3,0,18
1998,Evidence for dopamine release during a videogame using [11C]Raclopride PET,"Grasby P.M., Koepp M.J., Gunn R.N., Cunningham V.J., Lawrence A.D., Dagher A., Jones T., Brooks D.J., Bench C.J.",10538119,NeuroImage,7,4,0,0,0,0,0,0
1998,Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI,"Samuel M., Williams S.C.R., Leigh P.N., Simmons A., Chakraborti S., Andrew C.M., Fristen K.J., Goldstein L.H., Brooks D.J.",283878,Neurology,51,6,19,0,3,3,1,23
1998,"Mach-Zehnder type, evanescent-wave sensor, using periodically segmented waveguide","Weissman Z., Brand E., Tsimberov I., Brooks D., Ruschin S.",10928081,Conference Proceedings - Lasers and Electro-Optics Society Annual Meeting-LEOS,2, ,0,0,0,0,1,1
1998,The role of the lateral premotor cortex in conditional and imitated praxis,"Brett M., Stein J.F., Brooks D.J.",10538119,NeuroImage,7,4,2,0,0,0,0,2
1998,Functional imaging of tremor,"Boecker H., Brooks D.J.",8853185,Movement Disorders,13,3,27,0,1,1,3,31
1998,Consensus statement of the Movement Disorder Society on tremor,"Deuschl G., Fahn S., Findley L.J., Hallett M., Jankovic J., Koller W.C., Krack P., Lang A.E., Lees A., Lucking C.H., Marsden C.D., Bain P., Obeso J.A., Oertel W.H., Poewe W., Pollak P., Quinn N., Rothwell J.C., Shibasaki H., Thompson P., Toloso E., Brin M., Agid Y., Benabid L., Benecke R., Berardelli A., Brooks D.J., Elble R.",8853185,Movement Disorders,13,3,278,53,48,101,34,413
1998,Activation positron emission tomography scanning in dystonia.,"Ceballos-Baumann A.O., Brooks D.J.",913952,Advances in neurology,78, ,14,0,0,0,1,15
1998,Cerebral control of unimanual and bimanual movements: An H215O PET study,"Goerres G.W., Samuel M., Jenkins I.H., Brooks D.J.",9594965,NeuroReport,9,16,31,2,2,4,0,35
1998,"Re: Fentanyl, morphine, and constipation [2] (multiple letters)","Davies A., Prentice W., Ahmedzai S.H., Brooks D.J.",8853924,Journal of Pain and Symptom Management,16,3,1,0,0,0,0,1
1998,Focal cortical release of endogenous opioids during reading-induced seizures,"Koepp M.J., Richardson M.P., Brooks D.J., Duncan J.S.",1406736,Lancet,352,9132,25,7,5,12,6,43
1998,The early diagnosis of Parkinson's disease,Brooks D.J.,3645134,Annals of Neurology,44,3,69,6,1,7,4,80
1998,Dopamine agonists and neuroprotection in Parkinson's disease,"Olanow C.W., Jenner P., Brooks D.",3645134,Annals of Neurology,44,3,90,5,6,11,6,107
1998,11C-flumazenil PET in neocortical epilepsy,"Richardson M.P., Koepp M.J., Brooks D.J., Duncan J.S.",283878,Neurology,51,2,48,2,2,4,2,54
1998,The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease,"Lawrence A.D., Weeks R.A., Brooks D.J., Andrews T.C., Watkins L.H.A., Harding A.E., Robbins T.W., Sahakian B.J.",68950,Brain,121,7,56,7,16,23,4,83
1998,Cerebral activation in malformations of cortical development,"Richardson M.P., Koepp M.J., Brooks D.J., Coull J.T., Grasby P., Fish D.R., Duncan J.S.",68950,Brain,121,7,47,5,5,10,0,57
1998,Olivopontocerebellar atrophy and multiple system atrophy: Clinical follow-up of 10 patients studied with PET [4],"Schrag A., Rinne J.O., Burn D.J., Mathias C.J., Marsden C.D., Brooks D.J., Quinn N.P.",3645134,Annals of Neurology,44,1,2,0,0,0,0,2
1998,"The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease","Schrag A.E., Brooks D.J., Brunt E., Fuell D., Korczyn A., Poewe W., Quinn N.P., Rascol O., Stocchi F.",3625664,Clinical Neuropharmacology,21,3,23,3,3,6,1,30
1998,In vivo [11C]Flumazenil-PET correlates with ex vivo [3H]Flumazenil autoradiography in hippocampal sclerosis,"Koepp M.J., Duncan J.S., Hand K.S.P., Labbe C., Richardson M.P., Van Paesschen W., Baird V.H., Cunningham V.J., Bowery N.G., Brooks D.J.",3645134,Annals of Neurology,43,5,44,3,3,6,2,52
1998,Positron emission tomography studies in movement disorders,Brooks D.J.,10423680,Neurosurgery Clinics of North America,9,2,14,0,0,0,0,14
1998,"A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease","Brooks D.J., Abbott R.J., Lees A.J., Martignoni E., Philcox D.V., Rascol O., Roos R.A.C., Sagar H.J.",3625664,Clinical Neuropharmacology,21,2,48,5,4,9,3,60
1998,Increased activation of frontal areas during arm movement in idiopathic torsion dystonia,"Playford E.D., Passingham R.E., Marsden C.D., Brooks D.J.",8853185,Movement Disorders,13,2,36,4,5,9,1,46
1998,Prefrontal cortex activity in people with schizophrenia and control subjects. Evidence from positron emission tomography for remission of 'hypofrontality' with recovery from acute schizophrenia,"Spence S.A., Hirsch S.R., Brooks D.J., Grasby P.M.",71250,British Journal of Psychiatry,172, ,71,6,2,8,4,83
1998,Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET,"Morrish P.K., Rakshi J.S., Bailey D.L., Sawle G.V., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,64,3,168,24,15,39,15,222
1998,"Comparison of EEG, MRI and PET in reading epilepsy: A case report","Koepp M.J., Hansen M.-L., Pressler R.M., Brooks D.J., Brandl U., Guldin B., Duncan J.S., Ried S.",9201211,Epilepsy Research,29,3,6,0,0,0,1,7
1998,Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H215O PET,"Boecker H., Brooks D.J., Dagher A., Ceballos-Baumann A.O., Passingham R.E., Samuel M., Friston K.J., Poline J.-B., Dettmers C., Conrad B.",223077,Journal of Neurophysiology,79,2,115,8,8,16,6,137
1998,Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study,"Rascol O., Brooks D.J., Brunt E.R., Korczyn A.D., Poewe W.H., Stocchi F.",8853185,Movement Disorders,13,1,94,6,4,10,3,107
1998,Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study,"Korczyn A.D., Brooks D.J., Brunt E.R., Poewe W.H., Rascol O., Stocchi F.",8853185,Movement Disorders,13,1,87,5,2,7,0,94
1998,"Erratum: Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements. An H215O PET study (Brain. Journal of Neurology (1997) 120, 8 (1301-1313))","Samuel M., Bakay R.A.E., Thomas D.G.T., Quinn N.P., Obeso J.A., Brooks D.J., Ceballos-Baumann A.O., Turjanski N., Boecker H., Gorospe A., Linazasoro G., Holmes A.P., DeLong M.R., Vitek J.L.",68950,Brain,121,4,0,0,0,0,0,0
1998,Erratum: Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H215O PET (Journal of Neurophysiology (February 1998) 79 (1070-1080)),"Boecker H., Brooks D.J., Dagher A., Ceballos-Baumann A.O., Passingham R.E., Samuel M., Friston K.J., Poline J.-B., Dettmers C., Conrad B.",223077,Journal of Neurophysiology,79,6,0,0,0,0,0,0
1998,"A study of medial pallidotomy for Parkinson's disease: Clinical outcome, MRI location and complications","Samuel M., Lees A.J., Quinn N.P., Caputo E., Brooks D.J., Schrag A., Scaravilli T., Branston N.M., Rothwell J.C., Marsden C.D., Thomas D.G.T.",68950,Brain,121,1,105,3,1,4,2,111
1998,Optimum delay and mean square error using CMA,"Brooks D.J., Lambotharan S., Chambers J.A.",7367791,"ICASSP, IEEE International Conference on Acoustics, Speech and Signal Processing - Proceedings",6, ,1,1,0,1,0,2
1998,Erratum: Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H215O PET (Journal of Neurophysiology (February 1998) 79 (1070-1080)),"Boecker H., Brooks D.J., Dagher A., Ceballos-Baumann A.O., Passingham R.E., Samuel M., Friston K.J., Poline J.-B., Dettmers C., Conrad B.",223077,Journal of Neurophysiology,79,4,0,0,0,0,0,0
1997,Basal ganglia function and dysfunction revealed by PET activation studies.,"Ceballos-Baumann A.O., Brooks D.J.",913952,Advances in neurology,74, ,10,2,1,3,0,13
1997,Parkinsonism associated with acute intracranial hematomas: An [18F]dopa positron-emission tomography study,"Turjanski N., Pentland B., Lees A.J., Brooks D.J.",8853185,Movement Disorders,12,6,9,1,0,1,2,12
1997,Spatial planning in normal and parkisonian subjects: A PET study,"Dagher A., Owen A.M., Brooks D.J.",10538119,NeuroImage,5,4,0,0,0,0,0,0
1997,Conceptual design of the high-resolution optical spectrograph for the Gemini South Telescope,"Diego Francisco, Walker David D., Brooks D., Charalambous Andrew, Crawford Ian A., D'Arrigo P., Dryburgh Mark, Jamshidi Heshmat, Radley Alan S., Savidge T.",0277786X,Proceedings of SPIE - The International Society for Optical Engineering,2871, ,2,0,0,0,0,2
1997,PET and SPECT studies in Parkinson's disease,Brooks D.J.,9610421,Bailliere's Clinical Neurology,6,1,25,1,3,4,0,29
1997,Movement selection without preparation does not activate the SMA,"Brett M., Jenkins I.H., Stein J.F., Brooks D.J.",10538119,NeuroImage,5,4,0,0,0,0,1,1
1997,Can the neuroprotective efficacy of an agent ever be conclusively proven?,"Morrish P.K., Rakshi J.S., Brooks D.J.",13515101,European Journal of Neurology,4,3,5,0,0,0,0,5
1997,PET and the investigation of dementia in the parkinsonian patient,"Turjanski N., Brooks D.J.",3036995,"Journal of Neural Transmission, Supplement",,51,18,0,0,0,0,18
1997,Optimised MSE and delay for blind equalizers,"Brooks D.J., Lambotharan S., Chambers J.A.",9633308,IEE Colloquium (Digest),,383,0,0,0,0,0,0
1997,A simple FMRI paradigm for mapping the major components of the human motor system,"Williams S.C.R., Allin M.B., Brooks D.J., Leigh P.N., Simmons A., Samuel M., Brammer M.J., Bullmore E.T., Goldstein L.H., Andrew C.M., Andrews C., Glover A.",10538119,NeuroImage,5,4,0,0,0,0,0,0
1997,Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias,"Piccini P., Weeks R.A., Brooks D.J.",3645134,Annals of Neurology,42,5,76,8,5,13,5,94
1997,Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data,"Richardson M.P., Fristen K.J., Sisodiya S.M., Koepp M.J., Ashburner J., Free S.L., Brooks D.J., Duncan J.S.",68950,Brain,120,11,61,4,7,11,2,74
1997,A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control),"Spence S.A., Brooks D.J., Hirsch S.R., Liddle P.F., Meehan J., Grasby P.M.",68950,Brain,120,11,139,25,19,44,11,194
1997,The effect of movement frequency on cerebral activation: A positron emission tomography study,"Jenkins I.H., Passingham R.E., Brooks D.J.",0022510X,Journal of the Neurological Sciences,151,2,50,4,0,4,5,59
1997,Cerebral glucose metabolism in corticobasal degeneration: Comparison with progressive supranuclear palsy and normal controls,"Nagahama Y., Fukuyama H., Turjanski N., Kennedy A., Yamauchi H., Ouchi Y., Kimura J., Brooks D.J., Shibasaki H.",8853185,Movement Disorders,12,5,29,1,2,3,1,33
1997,Central benzodiazepine/?-aminobutyric acid(A) receptors in idiopathic generalized epilepsy: An [11C]flumazenil positron emission tomography study,"Koepp M.J., Richardson M.P., Brooks D.J., Cunningham V.J., Duncan J.S.",139580,Epilepsia,38,10,33,4,3,7,4,44
1997,Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.,"Koepp M.J., Labbe C., Richardson M.P., Brooks D.J., Van Paesschen W., Cunningham V.J., Duncan J.S.",68950,Brain : a journal of neurology,120, ,9,2,3,5,6,20
1997,Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis,"Koepp M.J., Labbe C., Richardson M.P., Brooks D.J., Van Paesschen W., Cunningham V.J., Duncan J.S.",68950,Brain,120,10,32,0,0,0,0,32
1997,Motor disturbance and brain functional imaging in Parkinson's disease,Brooks D.J.,143022,European Neurology,38,2,13,0,0,0,0,13
1997,Advances in imaging Parkinson's disease,Brooks D.J.,13507540,Current Opinion in Neurology,10,4,16,1,0,1,3,20
1997,11C-diprenorphine binding in Huntington's disease: A comparison of region of interest analysis with statistical parametric mapping,"Weeks R.A., Cunningham V.J., Piccini P., Waters S., Harding A.E., Brooks D.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,17,9,37,5,2,7,0,44
1997,In vivo studies on striatal dopamine D1 and D2 site binding in L- dopa-treated Parkinson's disease patients with and without dyskinesias,"Turjanski N., Lees A.J., Brooks D.J.",283878,Neurology,49,3,70,6,4,10,6,86
1997,"11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy","Koepp M.J., Richardson M.P., Labbe C., Brooks D.J., Cunningham V.J., Ashburner J., Van Paesschen W., Revesz T., Duncan J.S.",283878,Neurology,49,3,58,4,4,8,0,66
1997,Cortical control of movement in Huntington's disease. A PET activation study,"Weeks R.A., Ceballos-Baumann A., Piccini P., Boecker H., Harding A.E., Brooks D.J.",68950,Brain,120,9,33,4,1,5,1,39
1997,Multi-branch DFE for Rayleigh fading multipath channels,"Brooks D.J., Chambers J.A.",135194,Electronics Letters,33,18,1,0,0,0,0,1
1997,Evaluation of the Short Parkinson's Evaluation Scale: A new friendly scale for the evaluation of Parkinson's disease in clinical drug trials,"Rabey J.M., Van Sauten W., Van Hilten B., Bass H., Bonuccelli U., Brooks D., Klotz P., Korczyn A.D., Kraus P., Martinez-Martin P., Morrish P.",3625664,Clinical Neuropharmacology,20,4,36,2,2,4,0,40
1997,Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements An H215O PET study,"Samuel M., Thomas D.G.T., Quinn N.P., Obeso J.A., Brooks D.J., Ceballos-Baumann A.O., Turjanski N., Boecker H., Gorospe A., Linazasoro G., Holmes A.P., DeLong M.R., Vitek J.L.",68950,Brain,120,8,113,3,4,7,4,124
1997,Dopaminergic function in patients with posttraumatic parkinsonism: An 18F-dopa PET study,"Turjanski N., Lees A.J., Brooks D.J.",283878,Neurology,49,1,5,1,0,1,0,6
1997,Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease,"Wenning G.K., Hagell P., Jahanshahi M., Sawle G., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., Lindvall O., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavii B.",3645134,Annals of Neurology,42,1,169,7,6,13,3,185
1997,Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study,"Samuel M., Ceballos-Baumann A.O., Blin J., Uema T., Boecker H., Passingham R.E., Brooks D.J.",68950,Brain,120,6,135,16,11,27,16,178
1997,Abnormal access of axial vibrotactile input to deafferented somatosensory cortex in human upper limb amputees,"Kew J.J.M., Halligan P.W., Marshall J.C., Passingham R.E., Rothwell J.C., Ridding M.C., David Marsden C., Brooks D.J.",223077,Journal of Neurophysiology,77,5,38,1,3,4,2,44
1997,The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour,"Fricker R.A., Torres E.M., Hume S.P., Myers R., Opacka-Juffrey J., Ashworth S., Brooks D.J., Dunnett S.B.",3064522,Neuroscience,79,3,59,4,3,7,1,67
1997,Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis,"Abrahams S., Goldstein L.H., Al-Chalabi A., Pickering A., Morris R.G., Passingham R.E., Brooks D.J., Leigh P.N.",223050,Journal of Neurology Neurosurgery and Psychiatry,62,5,62,16,6,22,7,91
1997,"Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life","Ahmedzai S., Brooks D.",8853924,Journal of Pain and Symptom Management,13,5,217,14,20,34,11,262
1997,Anatomy of motor learning. II. Subcortical structures and learning by trial and error,"Jueptner M., Frith C.D., Brooks D.J., Frackowiak R.S.J., Passingham R.E.",223077,Journal of Neurophysiology,77,3,195,19,16,35,8,238
1997,Anatomy of motor learning. I. Frontal cortex and attention to action,"Jueptner M., Stephan K.M., Frith C.D., Brooks D.J., Frackowiak R.S.J., Passingham R.E.",223077,Journal of Neurophysiology,77,3,263,28,21,49,8,320
1997,Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study,"Ceballos-Baumann A.O., Sheean G., Passingham R.E., Marsden C.D., Brooks D.J.",68950,Brain,120,4,81,9,8,17,6,104
1997,Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study,"Piccini P., Brooks D.J., Morrish P.K., Turjanski N., Sawle G.V., Burn D.J., Weeks R.A., Mark M.H., Maraganore D.M., Lees A.J.",3645134,Annals of Neurology,41,2,77,6,3,9,3,89
1997,Stereotactic thalamotomy in tremor-dominant parkinson's disease: An H215O PET motor activation study,"Boecker H., Wills A.J., Ceballos-Baumann A., Samuel M., Thomas D.G.T., Marsden C.D., Brooks D.J.",3645134,Annals of Neurology,41,1,24,1,0,1,1,26
1996,Comparison of Methods for Analysis of Clinical [1C]Raclopride Studies,"Lammertsma A.A., Bench C.J., Hume S.P., Osman S., Gunn K., Brooks D.J., Frackowiak R.S.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,16,1,156,16,23,39,18,213
1996,The sensory guidance of movement: A comparison of the cerebellum and basal ganglia,"Jueptner M., Jenkins I.H., Brooks D.J., Frackowiak R.S.J., Passingham R.E.",144819,Experimental Brain Research,112,3,33,5,5,10,0,43
1996,Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease,"Morrish P.K., Sawle G.V., Brooks D.J.",68950,Brain,119,6,49,0,6,6,1,56
1996,Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.,"Morrish P.K., Sawle G.V., Brooks D.J.",68950,Brain : a journal of neurology,119, ,9,0,2,2,3,14
1996,Frontal lobe dysfunction in amyotrophic lateral sclerosis: A PET study,"Abrahams S., Goldstein L.H., Kew J.J.M., Brooks D.J., Lloyd C.M., Frith C.D., Leigh P.N.",68950,Brain,119,6,70,12,7,19,8,97
1996,An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease,"Morrish P.K., Sawle G.V., Brooks D.J.",68950,Brain,119,2,165,7,9,16,4,185
1996,Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis,"Koepp M.J., Richardson M.P., Brooks D.J., Poline J.B., Van Paesschen W., Friston K.J., Duncan J.S.",68950,Brain,119,5,71,3,2,5,0,76
1996,Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: An 11C-flumazenil PET study,"Richardson M.P., Koepp M.J., Brooks D.J., Fish D.R., Duncan J.S.",3645134,Annals of Neurology,40,2,95,4,3,7,0,102
1996,Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects [1],"Botzel K., Schulze S., Jahanshahi M., Jenkins H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J.",68950,Brain,119,3,21,0,0,0,0,21
1996,Experimental characterization of coupled waveguides by normal-mode excitation,"Scarlat D., Ruschin S., Brooks D.",189197,IEEE Journal of Quantum Electronics,32,7,2,0,0,0,0,2
1996,Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease,"Weeks R.A., Piccini P., Harding A.E., Brooks D.J.",3645134,Annals of Neurology,40,1,78,10,5,15,4,97
1996,Tourette's syndrome: A disorder of cingulate and orbitofrontal function?,"Weeks R.A., Turjanski N., Brooks D.J.",335622,QJM - Monthly Journal of the Association of Physicians,89,6,23,2,0,2,3,28
1996,Tremor associated with benign IgM paraproteinaemic neuropathy,"Bain P.G., Britton T.C., Jenkins I.H., Thompson P.D., Rothwell J.C., Thomas P.K., Brooks D.J., Marsden C.D.",68950,Brain,119,3,35,3,4,7,2,44
1996,Nondestructive method for measuring the coupling between optical waveguides,"Brooks D., Ruschin S., Scarlat D.",1077260X,IEEE Journal on Selected Topics in Quantum Electronics,2,2,3,0,0,0,0,3
1996,The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.,"Morrish P.K., Sawle G.V., Brooks D.J.",913952,Advances in neurology,69, ,20,1,1,2,2,24
1996,Basal ganglia function during normal and parkinsonian movement. PET activation studies.,Brooks D.J.,913952,Advances in neurology,69, ,0,0,1,1,0,1
1996,The effect of ethanol on alcohol-responsive essential tremor: A position emission tomography study,"Boecker H., Wills A.J., Ceballos-Baumann A., Samuel M., Thompson P.D., Findley L.J., Brooks D.J.",3645134,Annals of Neurology,39,5,53,4,3,7,5,65
1996,An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.,"Morrish P.K., Sawle G.V., Brooks D.J.",68950,Brain : a journal of neurology,119, ,15,3,0,3,4,22
1996,Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter,"Hume S.P., Kuhar M.J., Brooks D.J., Luthra S.K., Brown D.J., Opacka-Juffry J., Osman S., Ashworth S., Myers R., Brady F., Carroll F.I.",9698051,Nuclear Medicine and Biology,23,3,14,2,0,2,0,16
1996,Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxic theory?,"Taylor-Robinson S.D., Weeks R.A., Bryant D.J., Sargentoni J., Marcus C.D., Harding A.E., Brooks D.J.",8853185,Movement Disorders,11,2,34,7,0,7,2,43
1996,The usefulness of functional imaging in movement disorders: An illustrative case [8],"Bhatia K.P., Turjanski N., Brooks D.J., Marsden C.D., Thrush D.",223050,Journal of Neurology Neurosurgery and Psychiatry,60,3,0,0,0,0,0,0
1996,A positron emission tomography study of primary orthostatic tremor,"Wills A.J., Thompson P.D., Findley L.J., Brooks D.J.",283878,Neurology,46,3,34,4,3,7,2,43
1996,Improved near-field method for refractive index measurement of optical waveguides,"Brooks David, Ruschin Shlomo",10411135,IEEE Photonics Technology Letters,8,2,6,2,0,2,2,10
1996,OGLP-400: an innovative computer-controlled polishing machine,"Kim Sug-Whan, Nixon Gil, Rees David, Walker David D., Bingham Richard G., Brooks David, Humm Brian, Jamshidi Heshmat, Kim Do-Hyung, Yang Ho-Soon",,Proceedings of SPIE - The International Society for Optical Engineering,2775, ,3,0,0,0,0,3
1996,Functional imaging techniques in the diagnosis of non-Alzheimer dementias,Brooks D.J.,3036995,"Journal of Neural Transmission, Supplement",,47,8,0,0,0,0,8
1995,Ropinirole in the symptomatic treatment of Parkinson's disease,"Brooks D.J., Torjanski N., Burn D.J.",3036995,"Journal of Neural Transmission, Supplement",,45,62,0,1,1,1,64
1995,Olivopontocerebellar atrophy [2],"Coplin W.M., Bird T.D., Rinne J.O., Burn D.J., Mathias C.J., Quinn N.P., Marsden C.D., Brooks D.J.",3645134,Annals of Neurology,38,6,0,0,0,0,0,0
1995,GDNF protects against 6-OHDA nigrostriatal lesion: In vivo study with microdialysis and PET,"Opacka-Juffry J., Ashworth S., Hume S.P., Martin D., Brooks D.J., Blunt S.B.",9594965,NeuroReport,7,1,50,2,0,2,0,52
1995,"Effect of L-Dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET","Hume S.P., Opacka-Juffry J., Myers R., Ahier R.G., Ashworth S., Brooks D.J., Lammertsma A.A.",8874476,Synapse,21,1,44,4,4,8,2,54
1995,"Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome - A [11C]diprenorphine PET study","Burn D.J., Rinne J.O., Quinn N.P., Lees A.J., Marsden C.D., Brooks D.J.",68950,Brain,118,4,37,4,3,7,3,47
1995,Integrated electrooptic multielectrode tunable filter,"Brooks David, Ruschin Shlomo",7338724,Journal of Lightwave Technology,13,7,7,1,2,3,0,10
1995,Benzodiazepine-GABA(A) receptor binding during absence seizures,"Prevett M.C., Lammertsma A.A., Brooks D.J., Cunningham V.J., Fish D.R., Duncan J.S.",139580,Epilepsia,36,6,19,0,0,0,0,19
1995,L-Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory roles,"Opacka-Juffry J., Brooks D.J.",8853185,Movement Disorders,10,3,27,1,0,1,0,28
1995,Motor reorganization in acquired hemidystonia,"Ceballos-Baumann A.O., Passingham R.E., Marsden C.D., Brooks D.J.",3645134,Annals of Neurology,37,6,66,1,2,3,0,69
1995,Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy,"Rinne J.O., Burn D.J., Mathias C.J., Quinn N.P., Marsden C.D., Brooks D.J.",3645134,Annals of Neurology,37,5,24,2,0,2,2,28
1995,A positron emission tomography study of cerebral activation associated with essential and writing tremor,"Wills A.J., Jenkins I.H., Thompson P.D., Findley L.J., Brooks D.J.",39942,Archives of Neurology,52,3,51,1,3,4,1,56
1995,Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia,"Ceballos-Baumann A.O., Passingham R.E., Warner T., Playford E.D., Marsden C.D., Brooks D.J.",3645134,Annals of Neurology,37,3,144,8,11,19,5,168
1995,Benzodiazepine-GABA(A) receptors in idiopathic generalized epilepsy measured with [11C]flumazenil and positron emission tomography,"Prevett M.C., Lammertsma A.A., Brooks D.J., Bartenstein P.A., Patsalos P.N., Fish D.R., Duncan J.S.",139580,Epilepsia,36,2,33,2,2,4,0,37
1995,The role of the basal ganglia in motor control: Contributions from PET,Brooks D.J.,0022510X,Journal of the Neurological Sciences,128,1,81,5,0,5,1,87
1995,Cognitive deficits in non-demented amyotrophic lateral sclerosis patients: A neuropsychological investigation,"Abrahams S., Goldstein L.H., Lloyd C.M., Brooks D.J., Leigh P.N.",0022510X,Journal of the Neurological Sciences,129, ,15,1,1,2,0,17
1995,A regional survey of opioid use by patients receiving specialist palliative care,"Brooks D.J., Gamble W., Ahmedzei S.",2692163,Palliative Medicine,9,3,13,3,3,6,1,20
1995,Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner,"Torres E.M., Fricker R.A., Hume S.P., Myers R., Opacka-Juffry J., Ashworth S., Brooks D.J., Dunnett S.B.",9594965,NeuroReport,6,15,34,3,1,4,0,38
1995,Personality correlates of [18F]dopa striatal uptake: Results of positron-emission tomography in Parkinson's disease,"Menza M.A., Mark M.H., Burn D.J., Brooks D.J.",8950172,Journal of Neuropsychiatry and Clinical Neurosciences,7,2,26,2,5,7,1,34
1995,Parkinson's disease-a single clinical entity?,Brooks D.J.,335622,Quarterly Journal of Medicine,88,2,6,0,0,0,0,6
1995,Relation between cerebral activity and force in the motor areas of the human brain,"Dettmers C., Frackowiak R.S.J., Fink G.R., Lemon R.N., Stephan K.M., Passingham R.E., Silbersweig D., Holmes A., Ridding M.C., Brooks D.J.",223077,Journal of Neurophysiology,74,2,216,15,17,32,13,261
1995,Self-initiated versus externally triggered movements - I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects,"Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., Brooks D.J.",68950,Brain,118,4,341,31,28,59,25,425
1995,Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs,"Playford E.D., Britton T.C., Thompson P.D., Brooks D.J., Findley L.J., Marsden C.D.",223050,Journal of Neurology Neurosurgery and Psychiatry,58,4,3,0,0,0,0,3
1995,PET studies of the striatal dopaminergic system in Parkinson's disease (PD),"Piccini P., Turjanski N., Brooks D.J.",3036995,"Journal of Neural Transmission, Supplement",,45,11,1,0,1,0,12
1995,Clinical and [(18F)]dopa PET findings in early Parkinson's disease,"Morrish P.K., Sawle G.V., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,59,6,98,4,5,9,10,117
1995,Demonstration of thalamic activation during typical absence seizures using H215O and PET,"Prevett M.C., Duncan J.S., Jones T., Fish D.R., Brooks D.J.",283878,Neurology,45,7,68,5,3,8,2,78
1995,Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study,"Turjanski N., Weeks R., Dolan R., Harding A.E., Brooks D.J.",68950,Brain,118,3,65,5,3,8,3,76
1995,A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis,"Abrahams S., Leigh P.N., Kew J.J.M., Goldstein L.H., Lloyd C.M.L., Brooks D.J.",0022510X,Journal of the Neurological Sciences,129, ,22,2,1,3,1,26
1995,Treatment for cancer pain [11],"Ahmedzai S., Brooks D.J.",9598146,British Medical Journal,311,7010,0,0,0,0,0,0
1995,Palliative care in general practice. Should GPs do it at the expense of commoner problems? [9],"Brooks D., Charlton R.",9598146,British Medical Journal,311,7018,2,0,0,0,0,2
1995,The functional anatomy of remembered saccades: A PET study,"O'Sullivan E.P., Jenkins I.H., Henderson L., Kennard C., Brooks D.J.",9594965,NeuroReport,6,16,67,2,1,3,0,70
1994,Positron emission tomography and central neurotransmitter systems in movement disorders,"Weeks R.A., Brooks D.J.",7673981,Fundamental and Clinical Pharmacology,8,6,6,0,0,0,0,6
1994,Red nuclear and cerebellar but no olivary activation associated with essential tremor: A positron emission tomographic study,"Wills A.J., Jenkins I.H., Thompson P.D., Findley L.J., Brooks D.J.",3645134,Annals of Neurology,36,4,77,5,1,6,1,84
1994,Cortical control of saccades and fixation in man: A PET study,"Anderson T.J., Jenkins I.H., Brooks D.J., Hawken M.B., Frackowiak R.S.J., Kennard C.",68950,Brain,117,5,191,9,3,12,7,210
1994,Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease [1],"Ceballos-Baumann A.O., Obeso J.A., Vitek J.L., Delong M.R., Bakay R., Linazasoro G., Brooks D.J.",1406736,Lancet,344,8925,80,2,1,3,1,84
1994,Depression in Parkinson's disease. A positron emission study,"Ring H.A., Bench C.J., Trimble M.R., Brooks D.J., Frackowiak R.S.J., Dolan R.J.",71250,British Journal of Psychiatry,165, ,110,5,8,13,5,128
1994,Opiate receptors in idiopathic generalised epilepsy measured with [11C]diprenorphine and positron emission tomography,"Prevett M.C., Cunningham V.J., Brooks D.J., Fish D.R., Duncan J.S.",9201211,Epilepsy Research,19,1,17,1,1,2,0,19
1994,Cortical function in progressive muscular atrophy and amyotrophic lateral sclerosis,"Kew J.J.M., Brooks D.J., Rassingham R.E., Rothwell J.C., Frackowiak R.S.J., Leigh P.N.",0022510X,Journal of the Neurological Sciences,124, ,2,0,0,0,0,2
1994,The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: Implications for levodopa therapy of Parkinson's disease,"Sawle G.V., Burn D.J., Morrish P.K., Lammertsma A.A., Snow B.J., Luthra S., Osman S., Brooks D.J.",283878,Neurology,44,7,51,4,2,6,0,57
1994,Glutamate in Huntington's disease [3],"Reynolds G.P., Pearson S.J., Bryant D.J., Weeks R.A., Marcus C.D., Sargentoni J., Taylor-Robinson S., Brooks D.J.",1406736,Lancet,344,8916,7,0,0,0,0,7
1994,Motor sequence learning: A study with positron emission tomography,"Jenkins I.H., Brooks D.J., Nixon P.D., Frackowiak R.S.J., Passingham R.E.",2706474,Journal of Neuroscience,14,6,535,30,27,57,15,607
1994,Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: A comparative PET study,"Kew J.J.M., Brooks D.J., Passingham R.E., Rothwell J.C., Frackowiak R.S.J., Leigh P.N.",283878,Neurology,44,6,45,5,4,9,2,56
1994,Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy [23],"Taylor-Robinson S.D., Weeks R.A., Sargentoni J., Marcus C.D., Bryant D., Harding A.E., Brooks D.J.",1406736,Lancet,343,8906,0,0,0,0,0,0
1994,Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy.,"Taylor-Robinson S.D., Weeks R.A., Sargentoni J., Marcus C.D., Bryant D.J., Harding A.E., Brooks D.J.",1406736,Lancet,343,8906,13,1,1,2,1,16
1994,Tourette's syndrome and the opioid system [21],"Weeks R.A., Lees A.J., Brooks D.J.",1406736,Lancet,343,8905,3,0,0,0,0,3
1994,Separating Parkinson's disease from normality: Discriminant function analysis of fluorodopa F 18 positron emission tomography data,"Sawle G.V., Playford E.D., Burn D.J., Cunningham V.J., Brooks D.J.",39942,Archives of Neurology,51,3,39,1,1,2,4,45
1994,"Nigrostriatal function in vitamin E deficiency: Clinical, experimental, and positron emission tomographic studies","Dexter D.T., Brooks D.J., Harding A.E., Burn D.J., Muller D.P.R., Goss-Sampson M.A., Jenner P.G., Marsden C.D.",3645134,Annals of Neurology,35,3,23,0,0,0,1,24
1994,Late presentation of Kartagener's syndrome,"Perraudeau M., Scott J., Walport M., Oakley C., Bloom S., Brooks D.",9598146,British Medical Journal,308,6927,8,0,1,1,0,9
1994,Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease,"Lindvall O., Odin P., Rehncrona S., Sawle G., Widner H., Rothwell J.C., Bjorklund A., Brooks D., Brundin P., Frackowiak R., Marsden C.D.",3645134,Annals of Neurology,35,2,192,7,9,16,7,215
1994,Steroid-responsive chorea in childhood following cardiac transplantation,"Blunt S.B., Brooks D.J., Kennard C.",8853185,Movement Disorders,9,1,2,0,0,0,0,2
1994,PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome,"Turjanski N., Sawle G.V., Playford E.D., Weeks R., Lammerstma A.A., Lees A.J., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,57,6,49,4,2,6,3,58
1994,Reorganization of cortical blood flow and transcranial magnetic stimulation maps in human subjects after upper limb amputation,"Kew J.J.M., Ridding M.C., Rothwell J.C., Passingham R.E., Leigh P.N., Sooriakumaran S., Frackowiak R.S.J., Brooks D.J.",223077,Journal of Neurophysiology,72,5,121,8,2,10,8,139
1994,"Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: Discriminant analysis of striatal 18F-dopa PET data","Burn D.J., Sawle G.V., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,57,3,89,2,7,9,5,103
1994,PET studies in progressive supranuclear palsy,Brooks D.J.,3036995,"Journal of Neural Transmission, Supplement",,42,21,1,1,2,0,23
1993,Investigation of the opioid system in absence seizures with positron emission tomography,"Bartenstein P.A., Duncan J.S., Prevett M.C., Cunningham V.J., Fish D.R., Jones A.K.P., Luthra S.K., Sawle G.V., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,56,12,34,2,1,3,2,39
1993,PET studies on the early and differential diagnosis of Parkinson's disease,Brooks D.J.,283878,Neurology,43,12,64,1,0,1,0,65
1993,The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: A neuropsychological and positron emission tomography study,"Kew J.J.M., Goldstein L.H., Leigh P.N., Abrahams S., Cosgrave N., Passingham R.E., Frackowiak R.S.J., Brooks D.J.",68950,Brain,116,6,86,14,8,22,4,112
1993,Striatal [18F]dopa uptake in familial idiopathic dystonia.,"Playford E.D., Fletcher N.A., Sawle G.V., Marsden C.D., Brooks D.J.",68950,Brain,116, ,3,0,1,1,1,5
1993,Functional imaging in relation to parkinsonian syndromes,Brooks D.J.,0022510X,Journal of the Neurological Sciences,115,1,43,2,2,4,1,48
1993,Nigral dysfunction in drug-induced parkinsonism: An 18F-dopa PET study,"Burn D.J., Brooks D.J.",283878,Neurology,43, 3 I,34,4,2,6,4,44
1993,Arsenic and mercury intoxication due to Indian ethnic remedies,"Kew J., Morris C., Aihie A., Fysh R., Jones S., Brooks D.",9598146,British Medical Journal,306,6876,54,4,4,8,2,64
1993,Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive Parkinsonism. Diagnostic implications of the D2 receptor status,"Sawle G.V., Playford E.D., Brooks D.J., Quinn N., Frackowiak R.S.J.",68950,Brain,116,4,54,4,6,10,2,66
1993,Functional imaging of the brain. Current state of positron emission tomography,Brooks D.J.,11209976,Rivista di Neuroradiologia,6,2,1,0,0,0,0,1
1993,The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease,"Vidailhet M., Stocchi F., Rothwell J.C., Thompson P.D., Day B.L., Brooks D.J., Marsden C.D.",283878,Neurology,43,9,21,2,1,3,0,24
1993,Striatal [18F]dopa uptake in familial idiopathic dystonia,"Playford E.D., Fletcher N.A., Sawle G.V., Marsden C.D., Brooks D.J.",68950,Brain,116,5,16,1,0,1,0,17
1993,"Comparison of striatal 18F-dopa uptake in adult-onset dystonia- parkinsonism, Parkinson's disease, and dopa-responsive dystonia","Turjanski N., Bhatia K., Burn D.J., Sawle G.V., Marsden C.D., Brooks D.J.",283878,Neurology,43,8,19,0,0,0,0,19
1993,Adult moyamoya disease,"Chaudhuri K.R., Edwards R., Scott J., Brooks D.J., Rees A., Pusey C.D.",9598146,British Medical Journal,307,6908,8,1,0,1,0,9
1993,Essential tremor and PD [5],"Jankovic J., Marsden C.D., Contant C., Perlmutter J., Brooks D.J., Playford E.D., Ibanez V., Sawle G.V., Thompson P.D., Findley L.",283878,Neurology,43,7,3,2,1,3,0,6
1993,Impaired activation of frontal areas during movement in Parkinson's disease: a PET study.,"Playford E.D., Jenkins I.H., Passingham R.E., Frackowiak R.S., Brooks D.J.",913952,Advances in neurology,60, ,23,1,2,3,1,27
1993,A positron emission tomography study of essential tremor: Evidence for overactivity of cerebellar connections,"Jenkins I.H., Bain P.G., Colebatch J.G., Thompson P.D., Findley L.J., Frackowiak R.S.J., Marsden C.D., Brooks D.J.",3645134,Annals of Neurology,34,1,102,7,5,12,7,121
1993,The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome,"Sawle G.V., Lees A.J., Hymas N.F., Brooks D.J., Frackowiak R.S.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,56,9,15,0,1,1,0,16
1993,Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study,"Kew J.J.M., Leigh P.N., Playford E.D., Passingham R.E., Goldstein L.H., Frackowiak R.S.J., Brooks D.J.",68950,Brain,116,3,103,10,2,12,7,122
1992,Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine,"Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S.J., Passingham R.E., Brooks D.J.",3645134,Annals of Neurology,32,6,180,14,9,23,13,216
1992,An analysis of motor learning,"Passingham R.E., Jueptner M., Frith C., Brooks D.J., Frackowiak R.S.J.",10870156,Nature Biotechnology,10,2,0,0,0,0,0,0
1992,The identification of presymptomatic parkinsonism: Clinical and [18F]dopa positron emission tomography studies in an Irish kindred,"Sawle G.V., Wroe S.J., Lees A.J., Brooks D.J., Frackowiak R.S.J.",3645134,Annals of Neurology,32,5,43,0,1,1,1,45
1992,Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography,"Hume S.P., Myers R., Bloomfield P.M., Opacka-Juffry J., Cremer J.E., Ahier R.G., Luthra S.K., Brooks D.J., Lammertsma A.A.",8874476,Synapse,12,1,98,8,7,15,5,118
1992,In vivo and in vitro studies of the dopaminergic system in movement disorders.,"Playford E.D., Brooks D.J.",10408827,Cerebrovascular and brain metabolism reviews,4,2,18,1,0,1,0,19
1992,Parkinson's disease in twins studied with 18F-dopa and positron emission tomography,"Burn D.J., Mark M.H., Playford E.D., Maraganore D.M., Zimmerman Jr. T.R., Duvoisin R.C., Harding A.E., Marsden C.D., Brooks D.J.",283878,Neurology,42,10,114,2,3,5,3,122
1992,Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study,"Playford E.D., Jenkins I.H., Passingham R.E., Nutt J., Frackowiak R.S.J., Brooks D.J.",3645134,Annals of Neurology,32,2,269,20,16,36,15,320
1992,"Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography","Brooks D.J., Frackowiak R.S.J., Ibanez V., Sawle G.V., Playford E.D., Quinn N., Mathias C.J., Lees A.J., Marsden C.D., Bannister R.",3645134,Annals of Neurology,31,2,196,14,4,18,6,220
1992,Normal aging of the nervous system [4],"Sawle G.V., Brooks D.J., Calne D.B., Eisen A., Meneilly G.",3645134,Annals of Neurology,31,5,1,0,0,0,0,1
1992,PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome.,"Brooks D.J., Turjanski N., Sawle G.V., Playford E.D., Lees A.J.",913952,Advances in neurology,58, ,15,0,1,1,0,16
1992,Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease,"Freed C.R., Wells T.H., Ramig L.O., Thompson L., Mazziotta J.C., Huang S.C., Grafton S.T., Brooks D., Sawle G., Schroter G., Ansari A.A., Breeze R.E., Rosenberg N.L., Schneck S.A., Kriek E., Qi J.-X., Lone T., Zhang Y.-B., Snyder J.A.",284793,New England Journal of Medicine,327,22,283,9,14,23,4,310
1992,Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants,"Sawle G.V., Widner H., Frackowiak R.S.J., Bloomfield P.M., Bjorklund A., Brooks D.J., Brundin P., Leenders K.L., Lindvall O., Marsden C.D., Rehncrona S.",3645134,Annals of Neurology,31,2,83,0,3,3,2,88
1992,Core assessment program for intracerebral transplantations (CAPIT),"Langston J.W., Widner H., Goetz C.G., Brooks D., Fahn S., Freeman T., Watts R.",8853185,Movement Disorders,7,1,492,32,31,63,20,575
1992,Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study,"Brooks D.J., Playford E.D., Ibanez V., Sawle G.V., Thompson P.D., Findley L.J., Marsden C.D.",283878,Neurology,42,8,73,11,14,25,4,102
1991,Detection of preclinical Parkinson's disease with PET.,Brooks D.J.,0016867X,Geriatrics,46, ,8,3,1,4,2,14
1991,Detection of preclinical Parkinson's disease with PET.,Brooks D.J.,283878,Neurology,41,5,23,0,0,0,0,23
1991,The functional anatomy of motor recovery after stroke in humans: A study with positron emission tomography,"Chollet F., DiPiero V., Wise R.J.S., Brooks D.J., Dolan R.J., Frackowiak R.S.J.",3645134,Annals of Neurology,29,1,423,31,30,61,21,505
1991,The diagnosis of multiple system atrophy [3],"Caraceni T., Brooks D.J.",3645134,Annals of Neurology,29,6,4,0,0,0,0,4
1991,Diffuse Lewy body disease presenting with a supranuclear gaze palsy,"Fearnley J.M., Revesz T., Brooks D.J., Frackowiak R.S.J., Lees A.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,54,2,39,2,0,2,2,43
1991,Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography,"Sawle G.V., Brooks D.J., Marsden C.D., Frackowiak R.S.J.",68950,Brain,114, 1 B,103,5,2,7,1,111
1991,Peripheral neuropathy associated with lithium toxicity [7],"Johnston S.R.D., Burn D.J., Brooks D.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,54,11,4,0,0,0,0,4
1991,Dopa-responsive dystonia: {18F}dopa positron emission tomography,"Sawle G.V., Leenders K.L., Brooks D.J., Harwood G., Lees A.J., Frackowiak R.S.J., Marsden C.D.",3645134,Annals of Neurology,30,1,33,0,0,0,3,36
1991,The clinical role of PET in cerebrovascular disease,Brooks D.J.,3445607,Neurosurgical Review,14,2,5,0,0,0,0,5
1991,PET: Its clinical role in neurology,Brooks D.J.,223050,Journal of Neurology Neurosurgery and Psychiatry,54,1,7,0,0,0,0,7
1991,Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: A positron emission tomographic study,"Brooks D.J., Ibanez V., Playford E.D., Sawle G.V., Leigh P.N., Kocen R.S., Harding A.E., Marsden C.D.",3645134,Annals of Neurology,30,2,21,2,0,2,0,23
1990,The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease,"Leenders K.L., Salmon E.P., Tyrrell P., Perani D., Brooks D.J., Sager H., Jones T., Marsden C.D., Frackowiak R.S.J.",39942,Archives of Neurology,47,12,193,7,7,14,8,215
1990,Striatal function in normal aging: Implications for Parkinson's disease,"Sawle G.V., Colebatch J.G., Shah A., Brooks D.J., Marsden C.D., Frackowiak R.S.J.",3645134,Annals of Neurology,28,6,67,3,2,5,2,74
1990,Positron emission tomography studies of neurotransmitter systems,"Sawle G.V., Brooks D.J.",3405354,Journal of Neurology,237,8,3,0,0,0,0,3
1990,Preliminary report: Activation of the cerebellum in essential tremor,"Colebatch J.G., Findley L.J., Frackowiak R.S.J., Marsden C.D., Brooks D.J.",1406736,Lancet,336,8722,58,1,3,4,3,65
1990,"The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET","Brooks D.J., Salmon E.P., Mathias C.J., Quinn N., Leenders K.L., Bannister R., Marsden C.D., Frackowiak R.S.J.",68950,Brain,113,5,122,3,7,10,6,138
1990,"Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age","Leenders K.L., Herold S., Beaney R.P., Brooks D.J., Spinks T., Rhodes C., Frackowiak R.S.J., Jones T., Perani D., Lammertsma A.A., Heather J.D., Buckingham P., Healy M.J.R., Gibbs J.M., Wise R.J.S., Hatazawa J.",68950,Brain,113,1,275,25,26,51,24,350
1990,A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography,"Salmon E., Brooks D.J., Leenders K.L., Turton D.R., Hume S.P., Cremer J.E., Jones T., Frackowiak R.S.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,10,3,26,0,0,0,1,27
1990,"Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","Brooks D.J., Ibanez V., Sawle G.V., Quinn N., Lees A.J., Mathias C.J., Bannister R., Marsden C.D., Frackowiak R.S.J.",3645134,Annals of Neurology,28,4,256,15,8,23,12,291
1989,Positron emission tomographic studies of the subcortical degenerations and dystonia,Brooks D.J.,2718235,Seminars in Neurology,9,4,1,0,0,0,0,1
1989,Dyskinesia in the elderly presenting as respiratory disorder,"Godlee F.N., Brooks D.J., Impallomeni M.",325473,Postgraduate Medical Journal,65,769,2,0,0,0,0,2
1989,PET and movement disorders,"Brooks D.J., Frackowiak R.S.J.",223050,Journal of Neurology Neurosurgery and Psychiatry,52, ,10,0,0,0,0,10
1989,Does signal-attenuation of high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels,"Brooks D.J., Luthert P., Gadian D., Marsden C.D.",223050,Journal of Neurology Neurosurgery and Psychiatry,52,1,25,4,4,8,2,35
1989,"The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine","Brooks D.J., Redmond S., Mathias C.J., Bannister R., Symon L.",223050,Journal of Neurology Neurosurgery and Psychiatry,52,8,38,2,2,4,2,44
1988,Use of magnetic resonance imaging to identify changes in cerebral blood flow in epilepsia partialis continua,"Fish D.R., Brooks D.J., Young I.R., Bydder G.M.",7403194,Magnetic Resonance in Medicine,8,2,5,0,1,1,0,6
1987,Regional cerebral blood flow of patients with focal epilepsy studied using xenon enhanced CT brain scanning,"Fish D.R., Lewis T.T., Brooks D.J., Zilkha E., Wise R.J.S., Kendall B.E.",223050,Journal of Neurology Neurosurgery and Psychiatry,50,12,1,0,0,0,0,1
1987,Measurement of glucose utilisation with [18F]2-fluoro-2-deoxy-D-glucose: A comparison of different analytical methods,"Lammertsma A.A., Brooks D.J., Frackowiak R.S.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,7,2,26,0,0,0,3,29
1987,The role of delayed computed tomographic scanning using high dose of contrast material in detecting cerebral demyelination in patients with multiple sclerosis in relapse and remission,"Brooks D.J., Carr D.H., Legg N.J.",71285,British Journal of Radiology,60,711,0,0,0,0,0,0
1987,Effects of dexamethasone in brain tumour patients,"Beaney R.P., Leenders K.L., Brooks D.J.",1406736,Lancet,1,8532,1,0,0,0,0,1
1987,Absence of irradiation induced ischaemic temporal lobe damage in patients with pituitary tumours,"Beaney R.P., Gibbs J.S.R., Brooks D.J.",0167594X,Journal of Neuro-Oncology,5,2,2,0,0,0,0,2
1986,Opisthotonos and benzodiazepine withdrawal in the elderly,"Speirs C.J., Navey F.L., Brooks D.J., Impallomeni M.G.",1406736,Lancet,2,8515,1,0,0,0,0,1
1986,"Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.","Leenders K.L., Frackowiak R.S., Quinn N., Brooks D., Sumner D., Marsden C.D.",8853185,Movement disorders : official journal of the Movement Disorder Society,1,1,19,0,0,0,1,20
1986,Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of 11CO2 and positron emission tomography,"Brooks D.J., Beaney R.P., Thomas D.G.T.",0271678X,Journal of Cerebral Blood Flow and Metabolism,6,5,4,1,0,1,0,5
1986,Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumors using positron emission tomography,"Brooks D.J., Beaney R.P., Lammertsma A.A.",262862,Microvascular Research,31,3,5,1,0,1,0,6
1986,Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography,"Brooks D.J., Gibbs J.S.R., Sharp P.",0271678X,Journal of Cerebral Blood Flow and Metabolism,6,2,28,1,1,2,2,32
1986,Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography,"Brooks D.J., Beaney R.P., Lammertsma A.A.",0271678X,Journal of Cerebral Blood Flow and Metabolism,6,2,14,0,1,1,1,16
1986,"A comparison between regional cerebral blood flow measurements obtained in human subjects using 11C-methylalbumin microspheres, the C15O2 steady-state method, and positron emission tomography","Brooks D.J., Frackowiak R.S.J., Lammertsma A.A.",16314,Acta Neurologica Scandinavica,73,4,5,0,3,3,0,8
1986,"Studies on cerebral oxygen metabolism, blood flow, and blood volume, in patients with hydrocephalus before and after surgical decompression, using positron emission tomography","Brooks D.J., Beaney R.P., Powell M.",68950,Brain,109,4,14,3,1,4,0,18
1986,The role of positron emission tomography in the study of cerebral tumors,"Brooks D.J., Beaney R.P., Thomas D.G.T.",937754,Seminars in Oncology,13,1,3,0,0,0,0,3
1985,"Dexamethasone treatment of brain tumor patients: Effects on regional cerebral blood flow, blood volume, and oxygen utilization","Leenders K.L., Beaney R.P., Brooks D.J.",283878,Neurology,35,11,27,1,1,2,1,30
1985,"Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery","Beaney R.P., Brooks D.J., Leenders K.L.",223050,Journal of Neurology Neurosurgery and Psychiatry,48,4,18,0,1,1,0,19
1985,"Regional cerebral oxygen utilization, blood flow, and blood volume in benign intracranial hypertension studied by positron emission tomography","Brooks D.J., Beaney R.P., Leenders K.L.",283878,Neurology,35,7,17,1,1,2,0,19
1984,A method to quantitate the fractional extraction of rubidium-82 across the blood-brain barrier using positron emission tomography,"Lammertsma A.A., Brooks D.J., Frackowiak R.S.J.",0271678X,Journal of Cerebral Blood Flow and Metabolism,4,4,3,0,0,0,0,3
1984,Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis,"Brooks D.J., Leenders K.L., Head G.",223050,Journal of Neurology Neurosurgery and Psychiatry,47,11,37,1,3,4,1,42
1984,Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography,"Brooks D.J., Beaney R.P., Lammertsma A.A.",0271678X,Journal of Cerebral Blood Flow and Metabolism,4,4,16,1,2,3,0,19
1984,Positron emission tomography in the study of cerebral tumours,"Thomas D.G.T., Beaney R.P., Brooks D.J.",3445607,Neurosurgical Review,7,4,1,0,0,0,0,1
1984,Measurement of regional cerebral pH in human subjects using continuous inhalation of 11CO2 and positron emission tomography,"Brooks D.J., Lammertsma A.A., Beaney R.P.",0271678X,Journal of Cerebral Blood Flow and Metabolism,4,3,12,0,3,3,4,19
1984,In vivo measurement of regional cerebral haematocrit using positron emission tomography,"Lammertsma A.A., Brooks D.J., Beaney R.P.",0271678X,Journal of Cerebral Blood Flow and Metabolism,4,3,41,3,0,3,3,47
1984,Pre-synaptic and post-synaptic dopaminergic system in human brain,"Leenders K.L., Herold S., Brooks D.J.",1406736,Lancet,2,8394,4,0,0,0,0,4
1983,"Recurrent salmonella septicaemia with aortitis, osteomylitis and psoas abscess","Brooks D.J., Cant A.J., Lambert H.P., Wansbrough-Jones M.H.",1634453,Journal of Infection,7,2,11,0,0,0,0,11
1976,The interaction of ligands with chemically modified phosphorylase b,"Brooks D., Busby S.J.W., Griffiths J.R.",84018,Canadian Journal of Biochemistry,54,5,0,0,0,0,0,0
1974,Studies on ligand binding during the conversion of phosphorylase b to phosphorylase a,"Brooks D.J., Busby S.J.W., Radda G.K.",142956,European Journal of Biochemistry,48,2,0,0,0,0,0,0
